Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
6dc66ec478b2c4a0e9a7718f32a23ab24fb82a39d3543da51fe689e4d0fa49ff.png
simple
<table><tr><td>Peak number</td><td>Mass</td><td>Composition of ion</td></tr><tr><td>1</td><td>357.13</td><td>B ion: CHR</td></tr><tr><td>2</td><td>458.24</td><td>B ion: CHR_K</td></tr><tr><td>3</td><td>616.28</td><td>B ion: CHR_K_OH-D</td></tr><tr><td>4</td><td>718.32</td><td>B ion: CHR_K_OH-D_T</td></tr><tr><td>5</td><td>818.39</td><td>B ion: CHR_K_OH-D_T_T</td></tr><tr><td>6</td><td>905.42</td><td>B ion: CHR_K_OH-D_T_T_S</td></tr><tr><td>7</td><td>1036.41</td><td>B ion: CHR_K_OH-D_T_T_S_OH-D</td></tr><tr><td>Y1</td><td>1067.48</td><td>Y ion resulting from loss of chromophore acyl group</td></tr></table>
d4db1a4fa6e2942777d2618ef3b2dd38bba45370183a855d0e7eebd7bb0769ce.png
simple
<table><tr><td>Groups</td><td>Dose (mg/kg)</td><td>Water (ml)</td><td>Food (g)</td><td>Weight gain (day 7)</td><td>Weight gain (day 14)</td></tr><tr><td>Control</td><td>&#8212;</td><td>6.190 &#177; 0.31</td><td>4.697 &#177; 0.14</td><td>1.100 &#177; 0.46</td><td>1.100 &#177; 0.46</td></tr><tr><td>Treated</td><td>300</td><td>7.673 &#177; 0.31<sup>&#8727;</sup></td><td>5.536 &#177; 0.19<sup>&#8727;</sup></td><td>2.397 &#177; 0.64<sup>&#8727;</sup></td><td>0.772 &#177; 0.10</td></tr><tr><td>Treated</td><td>2000</td><td>6.884 &#177; 0.35</td><td>4.306 &#177; 0.25</td><td>&#8722;1.093 &#177; 0.38<sup>&#8727;</sup></td><td>0.375 &#177; 0.28</td></tr></table>
da6768cb9f5cbeb26bc07c78823d62c3374ef773b6f1ca40f8d4dd3027f21397.png
complex
<table><tr><td></td><td colspan="6">ABSOLUTE LATENCIES</td></tr><tr><td rowspan="2">GA/P</td><td colspan="2">I</td><td colspan="2">III</td><td colspan="2">V</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Preterm/P1</td><td>1.80</td><td>0.35</td><td>4.47</td><td>0.75</td><td>6.66</td><td>0.55</td></tr><tr><td>Preterm/P2</td><td>1.60</td><td>0.20</td><td>4.26</td><td>0.18</td><td>6.32</td><td>0.24</td></tr><tr><td>Preterm/P3</td><td>1.62</td><td>0.20</td><td>4.09</td><td>0.27</td><td>6.23</td><td>0.29</td></tr><tr><td>Full term/P1</td><td>1.67</td><td>0.28</td><td>4.49</td><td>0.47</td><td>6.77</td><td>0.54</td></tr><tr><td>Full term/P2</td><td>1.71</td><td>0.30</td><td>4.32</td><td>0.33</td><td>6.50</td><td>0.33</td></tr><tr><td>Full term/P3</td><td>1.71</td><td>0.20</td><td>3.97</td><td>0.28</td><td>6.23</td><td>0.30</td></tr></table>
818f221f79da52a3e869131472c3d998d5a9f6ba3d1b4e3c19b1fb2b63e3ec78.png
simple
<table><tr><td>Variable</td><td>Odds ratio</td><td>95% CI</td></tr><tr><td>Joint family</td><td>4.03</td><td>2.41-6.18</td></tr><tr><td>&gt; 2 birth order</td><td>3.09</td><td>2.16-4.19</td></tr><tr><td>Mother's education &#8804; 6<sup>th </sup>standard</td><td>3.81</td><td>2.37-5.96</td></tr><tr><td>Mother working</td><td>4.47</td><td>3.04-6.98</td></tr></table>
45e97f7f355c9b7cd6e6a7fb55d96ada3305d79d68fb38e80c6bb63188dbbda0.png
simple
<table><tr><td> </td><td>1997&#8211;2004</td><td>2005&#8211;2010</td><td>Increased %</td></tr><tr><td>AA + White</td><td>75.37%</td><td>87.62%</td><td>12.25%</td></tr><tr><td>AA</td><td>74.53%</td><td>87.15%</td><td>12.62%</td></tr><tr><td>White</td><td>78.70%</td><td>89.99%</td><td>11.29%</td></tr><tr><td>AA-Whitedifference</td><td>4.17%</td><td>2.84%</td><td>1.33%</td></tr></table>
8c980e351d67d2ce7d7f01995d140d64cfe106f97ae6dca57b812b2f73e52fc6.png
complex
<table><tr><td rowspan="3">Final identification (no of isolates)</td><td colspan="7">Number of isolates</td></tr><tr><td colspan="2">Conventional identification method (Vitek 2)</td><td colspan="2">VITEK MS identification</td><td colspan="2">Bruker MS identification</td><td>16S rRNA sequence results (number of discrepant organisms sequenced)</td></tr><tr><td>No ID</td><td>Mis - ID</td><td>No ID</td><td>Mis - ID</td><td>No ID</td><td>Mis - ID</td><td></td></tr><tr><td><i>Haemophilus influenzae</i> (8)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2 (score &lt;1.7)</td><td><i>H. influenzae</i> (2)</td></tr><tr><td><i>Neisseria cinerea</i> (1)</td><td>0</td><td>0</td><td>0</td><td>1 (<i>Neisseria subflava</i>)</td><td>0</td><td>1 (<i>Neisseria sicca</i>)</td><td><i>N. cinerea</i> (1)</td></tr><tr><td><i>Neisseria subflava</i> (5)</td><td>NA</td><td>NA</td><td>0</td><td>0</td><td>0</td><td><i>Neisseria flava</i> (5)</td><td><i>N. subflava</i> (5)</td></tr><tr><td><i>Neisseria meningitidis</i> (1)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td></td></tr><tr><td><i>Moraxella catarrhalis</i> (1)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td></td></tr></table>
a68b96b5d1b8a5863158e833c1bfe9113ab2f6ed9461c1842dfccaa0e026ec88.png
simple
<table><tr><td>Total expressed features</td><td>Overlapping features</td><td>EM</td><td>PL</td><td>ES</td><td>TS</td></tr><tr><td>13,718</td><td>EM</td><td></td><td>9,840</td><td>9,212</td><td>9,314</td></tr><tr><td>10,559</td><td>PL</td><td></td><td></td><td>8,508</td><td>8,881</td></tr><tr><td>9,667</td><td>ES</td><td></td><td></td><td></td><td>8,816</td></tr><tr><td>9,840</td><td>TS</td><td></td><td></td><td></td><td></td></tr><tr><td>Total expressed U-clusters</td><td>Overlapping U-clusters</td><td>EM</td><td>PL</td><td>ES</td><td>TS</td></tr><tr><td>11,360</td><td>EM</td><td></td><td>8,271</td><td>7,749</td><td>7,853</td></tr><tr><td>8,828</td><td>PL</td><td></td><td></td><td>7,181</td><td>7,492</td></tr><tr><td>8,101</td><td>ES</td><td></td><td></td><td></td><td>7,435</td></tr><tr><td>8,271</td><td>TS</td><td></td><td></td><td></td><td></td></tr><tr><td>Total expressed transcripts</td><td>Overlapping transcripts</td><td>EM</td><td>PL</td><td>ES</td><td>TS</td></tr><tr><td>11,762</td><td>EM</td><td></td><td>8,516</td><td>7,980</td><td>8,090</td></tr><tr><td>9,108</td><td>PL</td><td></td><td></td><td>7,386</td><td>7,718</td></tr><tr><td>8,357</td><td>ES</td><td></td><td></td><td></td><td>7,657</td></tr><tr><td>8,534</td><td>TS</td><td></td><td></td><td></td><td></td></tr></table>
4c0b0a71d9e518b262bd3125d7110b437b13a1fde3b4fe5cc7284c476e1c0a4d.png
complex
<table><tr><td rowspan="2">Year of point prevalence study</td><td colspan="2">MRSA</td><td colspan="2">VRE</td><td colspan="2">ESBL-EC (2012)3MRGN-EC (2014)</td><td colspan="2">ESBL-KS (2012)3MRGN-KP* (2014)</td><td colspan="2">CD</td></tr><tr><td colspan="2">Mean prevalence[95 % CI]</td><td colspan="2">Mean prevalence[95 % CI]</td><td colspan="2">Mean prevalence[95 % CI]</td><td colspan="2">Mean prevalence[95 % CI]</td><td colspan="2">Mean prevalence[95 % CI]</td></tr><tr><td>2012 [12]</td><td>1.53</td><td>[1.32 &#8211; 1.75]</td><td>0.27</td><td>[0.18 &#8211; 0.36]</td><td>0.97</td><td>[0.80 &#8211; 1.14]</td><td>0.33</td><td>[0.19 &#8211; 0.48]</td><td>1.30</td><td>[1.11 &#8211; 1.50]</td></tr><tr><td>2014</td><td>1.64</td><td>[1.46 &#8211; 1.82]</td><td>0.25</td><td>[0.13 &#8211; 0.37]</td><td>0.75</td><td>[0.60 &#8211; 0.89]</td><td>0.22</td><td>[0.15 &#8211; 0.29]</td><td>0.74</td><td>[0.60 &#8211; 0.88]</td></tr></table>
4d06daeb4870bcf8bf97fa3cf825dd001d7e987dd29226222c88aafb283be29e.png
complex
<table><tr><td>Primers and probes</td><td>Nucleic acid sequences of primers and probes</td></tr><tr><td colspan="2">qPCR Zika virus (ZIKV)</td></tr><tr><td> ZIKV forward</td><td>5-nt9271AARTACACATACCARAACAAAgTggT9297&#8211;3&#8217;</td></tr><tr><td> ZIKV reverse</td><td>5&#8242; nt9352-TCCRCTCCCYCTYTggTCTTg-9373 -3&#8217;</td></tr><tr><td> ZIKV probe</td><td>nt 9304-FAM-CTYAgACCAgCTgAAR-BBQ-9320</td></tr><tr><td colspan="2">qPCR Dengue total (DENV 1&#8211;4 system)</td></tr><tr><td> DENT forward</td><td>5&#8242;- AGGACYAGAGGTTAGAGGAGA - 3&#8217;</td></tr><tr><td> DENT reverse</td><td>5&#8242;- CGYTCTGTGCCTGGAWTGAT &#8722;3&#8217;</td></tr><tr><td> DENT probe</td><td>FAM-ACAGCATATTGACGCTGGGARAGACC-TAMRA</td></tr><tr><td colspan="2">qPCR Dengue subtypes (DENV1, DENV2, DENV3)</td></tr><tr><td> DEN1 forward</td><td>5&#8242; ATACCYCCAACAGCAGGAATT - 3&#8217;</td></tr><tr><td> DEN1 reverse</td><td>5&#8242; AGCATRAGGAGCATGGTCAC &#8722;3&#8217;</td></tr><tr><td> DEN1 probe</td><td>FAM-TTGGCTAGATGGRGCTCATTCAAGAAGAAT-TAMRA</td></tr><tr><td> DEN2 forward</td><td>5&#8242; TGGACCGACAAAGACAGATTCTT 3&#8217;</td></tr><tr><td> DEN2 reverse</td><td>5&#8242; CGYCCYTGCAGCATTCCAA 3&#8217;</td></tr><tr><td> DEN2 probe</td><td>FAM-CGCGAGAGAAACCGCGTGTCRACTGT-TAMRA</td></tr><tr><td> DEN3 forward</td><td>5&#8242; AAGACGGGAAAACCGTCTATCAA 3&#8217;</td></tr><tr><td> DEN3 reverse</td><td>5&#8242; TTGAGAATCTCTTCGCCAACTG 3&#8217;</td></tr><tr><td> DEN3 probe</td><td>FAM-ATGCTGAAACGCGTGAGAAACCGTGT-TAMRA</td></tr><tr><td colspan="2">qPCR Chikungunya (CHIK)</td></tr><tr><td> CHIK forward</td><td>5&#8242;- AAGCTYCGCGTCCTTTACCAAG - 3&#8217;</td></tr><tr><td> CHIK reverse</td><td>5&#8242;- CCAAATTGTCCYGGTCTTCCT &#8722;3&#8217;</td></tr><tr><td> CHIK probe</td><td>FAM-CCAATGTCYTCMGCCTGGACACCTTT-TAMRA</td></tr><tr><td colspan="2">qPCR Rift Valley fever virus (RVFV)</td></tr><tr><td> RVFV forward</td><td>5&#8242;- AAA ggA ACA ATg gAC TCT ggT CA - 3&#8217;</td></tr><tr><td> RVFV reverse</td><td>5&#8242;- CAC TTC TTA CTA CCA TTC CTC CAA T &#8722; 3&#8217;</td></tr><tr><td> RVFV probe</td><td>FAM-AAA gCT TTg ATA TCT CTC AgT gCC CCA A -TAMRA</td></tr><tr><td colspan="2">qPCR West Nile virus (WNV)</td></tr><tr><td> WNV3p forward</td><td>5&#8242; Agg TTA gWg gAg ACC CCg T - 3&#8217;</td></tr><tr><td> WNV3p reverse</td><td>5&#8242; ggT TgT gCA gAg CAg AAg ATC &#8722;3&#8217;</td></tr><tr><td> WNV3p probe</td><td>FAM-CGGTTCCGGCGGTGGTTTCT-TAMRA</td></tr><tr><td colspan="2">Conventional PCR Crimean-Congo haemorrhagic fever virus (CCHFV)</td></tr><tr><td> CCHFV forward</td><td>5&#8242; &#8211; TGGACACCTTCACAAACTC - 3&#8217;</td></tr><tr><td> CCHFV reverse</td><td>5&#8242; &#8211; GACAAATTCCCTGCACCA - 3&#8217;</td></tr><tr><td colspan="2">qPCR Hepatitis E virus (HEV)</td></tr><tr><td> HEV forward</td><td>5&#8242; GCCCGGTCAGCCGTCTGG &#8722;3&#8217;</td></tr><tr><td> HEV reverse</td><td>5&#8242;-CTGAGAATCAACCCGGTCAC &#8722;3&#8217;</td></tr><tr><td> HEV probe</td><td>FAM-CGGTTCCGGCGGTGGTTTCT-TAMRA</td></tr></table>
b0c90e9799809bc422190b047d679b7ece13512c174b6ad47dec6543e0d952bb.png
complex
<table><tr><td>Item number</td><td>Question description</td><td colspan="4">Expert raters</td><td>I-CVI<sup>a</sup></td></tr><tr><td></td><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td></td></tr><tr><td>Q1</td><td>Lifetime prevalence</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q2</td><td>Age of onset</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q3</td><td>Recurrent NSLBP<sup>c</sup></td><td>4</td><td>4</td><td>4</td><td>2</td><td>0.75</td></tr><tr><td>Q4</td><td>Frequency of recurrent NSLBP</td><td>4</td><td>4</td><td>4</td><td>3</td><td>1.00</td></tr><tr><td>Q5</td><td>Duration of recurrent NSLBP</td><td>2</td><td>4</td><td>4</td><td>4</td><td>0.75</td></tr><tr><td>Q6</td><td>Intensity of recurrent NSLBP</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q7</td><td>Sciatica</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q8</td><td>Point prevalence</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q9</td><td>Point pain intensity</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q10</td><td>Medical treatment</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q11a</td><td>Sitting on a chair</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>b)</td><td>Reaching up</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>c)</td><td>Standing</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>d)</td><td>Walking</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>e)</td><td>Sporting activity</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>f)</td><td>Bending</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>g)</td><td>School-bag carrying</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>h)</td><td>Sitting up in bed</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>i)</td><td>Running</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q12</td><td>Absenteeism</td><td>3</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q13</td><td>Bag carriage</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q14</td><td>Perception school-bag weight</td><td>4</td><td>4</td><td>4</td><td>3</td><td>1.00</td></tr><tr><td>Q15</td><td>Duration of carrying school-bag</td><td>3</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q16</td><td>Method of carrying school-bag</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q17</td><td>Sports participation</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q18</td><td>Type of sport</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q19</td><td>Sports duration</td><td>4</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q20</td><td>Sedentary time</td><td>3</td><td>4</td><td>4</td><td>4</td><td>1.00</td></tr><tr><td>Q21</td><td>Smoking</td><td>4</td><td>4</td><td>4</td><td>1</td><td>0.75</td></tr><tr><td>Q22</td><td>Past week smoking</td><td>4</td><td>4</td><td>4</td><td>1</td><td>0.75</td></tr><tr><td></td><td colspan="6"><sup>d</sup>Total agreement=0.86 <sup>b</sup>S-CVI/Ave = 0.97</td></tr></table>
fe30dca546cfab8fd66a74edcebe9cf60f992b49ebae2e2d71dacb51b8889699.png
complex
<table><tr><td></td><td colspan="2">Symptomatic Group (<i>n</i> = 30)</td><td colspan="2">Asymptomatic Group (<i>n</i> = 30)</td><td>Overall (<i>n</i> = 60)</td></tr><tr><td>GSRS-IBS Subdomains</td><td>Score &#8805; 2 (Any Discomfort), <i>n</i></td><td>Score &#8805; 4 (Moderate to Severe Discomfort), <i>n</i></td><td>Score &#8805; 2 (Any Discomfort), <i>n</i></td><td>Score &#8805; 4 (Moderate to Severe Discomfort), <i>n</i></td><td>Score &#8805; 2 (Any Discomfort), <i>n</i></td></tr><tr><td>Pain (Q1 or 2)</td><td>15 (50%)</td><td>11 (37%)</td><td>1 (3%)</td><td>0</td><td>16 (27%)</td></tr><tr><td>Bloating (Q3, 4 or 13)</td><td>24 (80%)</td><td>3 (10%)</td><td>7 (23%)</td><td>1 (3%)</td><td>31 (52%)</td></tr><tr><td>Constipation (Q5 or 8)</td><td>17 (57%)</td><td>8 (27%)</td><td>8 (27%)</td><td>3 (10%)</td><td>25 (42%)</td></tr><tr><td>Diarrhoea (Q6, 7, 9 or 10)</td><td>24 (80%)</td><td>10 (33%)</td><td>6 (20%)</td><td>0</td><td>30 (50%)</td></tr><tr><td>Satiety (Q11 or 12)</td><td>15 (50%)</td><td>3 (10%)</td><td>5 (17%)</td><td>2 (7%)</td><td>20 (33%)</td></tr></table>
bcbecc08804a3ca43bcf75aaa25a6fc8052a57e7629aa3ee55521492029d430c.png
complex
<table><tr><td>Time</td><td>Monday</td><td>Tuesday</td><td>Wednesday</td><td>Thursday</td><td>Friday</td></tr><tr><td>8 am &#8211; 10 am</td><td>Lecture (C1) / Morning session (C2)</td><td>Lecture (C1) / Morning session (C2)</td><td>Social and Population Health</td><td>Lecture (C1)/ Morning session (C2)</td><td rowspan="2">Primary Health / Community attachment</td></tr><tr><td>10 am-12:30 pm</td><td>Bedside teaching</td><td>Inpatient/ outpatient care</td><td>Inpatient/ outpatient care</td><td>Bedside teaching</td></tr><tr><td>12:30 pm- 2 pm</td><td>Lunch</td><td>Lunch</td><td>Lunch</td><td>Lunch</td><td>Lunch</td></tr><tr><td>2 pm&#8211;4 pm</td><td rowspan="2">Inpatient/ outpatient care</td><td>PCD</td><td rowspan="2">Inpatient/ outpatient care</td><td rowspan="2">Inpatient/ outpatient care</td><td rowspan="2">Whole group session seminar/journal club/grand round</td></tr><tr><td>4 pm-5:30 pm</td><td>Inpatient/ outpatient care</td></tr></table>
76501349064cfd3d58fa6a596eaaadde21a66b154a138a2db6ee5fb50cca9c89.png
simple
<table><tr><td>Adverse events</td><td>Placebo (n = 23)</td><td>100 mg/day 5-Loxin<sup>&#174; </sup>(n = 24)</td><td>250 mg/day 5-Loxin<sup>&#174; </sup>(n = 23)</td></tr><tr><td>Diarrhoea</td><td>3</td><td>2</td><td>2</td></tr><tr><td>Nausea</td><td>1</td><td>3</td><td>2</td></tr><tr><td>Vomiting</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Abdominal pain</td><td>4</td><td>2</td><td>2</td></tr><tr><td>Pedal edema</td><td>0</td><td>1</td><td>0</td></tr><tr><td>Itching</td><td>2</td><td>1</td><td>4</td></tr><tr><td>General weakness</td><td>2</td><td>4</td><td>2</td></tr><tr><td>Constipation</td><td>0</td><td>0</td><td>1</td></tr><tr><td>Mild fever (up to 37.5&#176;C)</td><td>1</td><td>2</td><td>2</td></tr><tr><td>Stomach burn</td><td>4</td><td>0</td><td>3</td></tr><tr><td>Allergy<sup>a</sup></td><td>3</td><td>0</td><td>1</td></tr><tr><td>Headache</td><td>0</td><td>0</td><td>1</td></tr><tr><td>Miscellaneous<sup>b</sup></td><td>9</td><td>2</td><td>6</td></tr><tr><td>Sum of events</td><td>30</td><td>18</td><td>27</td></tr></table>
75e2560cce0e3390fd49b228872fc85ffbc5951d1f12cd1b63ae21d994454aea.png
complex
<table><tr><td></td><td colspan="2">Femoral offset (mm)</td><td></td><td></td><td></td></tr><tr><td></td><td>Operated</td><td>Contralateral</td><td>Average diff</td><td>&lt; 4.62 mm diff</td><td>P value</td></tr><tr><td>Hip Resurfacing</td><td>50.71</td><td>50.63</td><td>-0.08</td><td>50%</td><td>0.9</td></tr><tr><td>Large-head metal on metal</td><td>51</td><td>56.56</td><td>+5.56</td><td>35%</td><td>0.0002</td></tr><tr><td>Total hip replacement</td><td>47.61</td><td>56.23</td><td>+8.62</td><td>30%</td><td>0.0003</td></tr></table>
b2ff0dcf4a9d4299ad28dfcc2ed4d528b9a9796600863315d5956644c09ab5a7.png
complex
<table><tr><td>Author</td><td>Country</td><td>Patients for score derivation (n)</td><td>Outcome</td><td>Patients with outcome n (%)</td><td>Maximum time between assessment and outcome measure</td><td>Variables</td><td>Performance</td></tr><tr><td>Sox<sup>a</sup> 1990 [35]</td><td>USA</td><td>1074</td><td>MIAnginaCoronary insufficiency</td><td>424 (39.5)</td><td>1 year</td><td>AgeGenderExertional painPatient stops activities when pain occursPMH of MISmokingPain relived by NTG</td><td>For score &gt; 4S:0.99Sp:0.18PPV:0.45NPV:0.98</td></tr><tr><td rowspan="2">Gencer 2010 [36]</td><td rowspan="2">Switzerland Germany</td><td rowspan="2">661</td><td rowspan="2">CAD</td><td rowspan="2">85 (12.9)</td><td rowspan="2">1 year</td><td rowspan="2">AgeGenderCV Risk KnownPain locationPain duration Exertional painPain on palpationPMH of CVD</td><td>AUC: 0.95 (0.92-0.97)</td></tr><tr><td>For scores &lt; 5(Lowest 5 % for patients with CAD):S:0.98Sp:0.71NPV:0.99</td></tr><tr><td rowspan="2">Bo&#776;sner 2010 [30]</td><td rowspan="2">Germany Switzerland</td><td rowspan="2">1199</td><td rowspan="2">CAD</td><td rowspan="2">180 (15.0)</td><td rowspan="2">6 months</td><td rowspan="2">AgeGenderExertional painPMH of CVDPatient assumes pain of cardiac originPain on palpation</td><td>AUC: 0.90 (0.87-0.93)</td></tr><tr><td>For a cut-off value of 3 (risk of CAD &gt; 35 %): S:0.86(0.79-0.92)Sp:0.75(0.72-0.78)PPV:0.35(0.29-0.41)NPV:0.97(0.96-0.98)</td></tr></table>
f96858f40c02754bf1f35ca2b0c3eec53020b0ac8e9b572d4f4bce389901d67e.png
simple
<table><tr><td>SCOP superfamily</td><td>PFAM name</td><td>Accession number</td></tr><tr><td>Ig</td><td>V-set</td><td>PF07686</td></tr><tr><td></td><td>I-set</td><td>PF07679</td></tr><tr><td></td><td>C2-set</td><td>PF05790</td></tr><tr><td></td><td>C1-set</td><td>PF07654</td></tr><tr><td></td><td>Ig</td><td>PF00047</td></tr><tr><td></td><td>Ig_2</td><td>PF13895</td></tr><tr><td></td><td>ICAM_N</td><td>PF03921</td></tr><tr><td>E-SET</td><td>Alpha_amylase_N</td><td>PF02903</td></tr><tr><td></td><td>arrestin_N</td><td>PF00339</td></tr><tr><td></td><td>arrestin_C</td><td>PF02752</td></tr><tr><td></td><td>CelD_N</td><td>PF02927</td></tr><tr><td></td><td>peptidaseC25</td><td>PF03785</td></tr><tr><td></td><td>TIG</td><td>PF01833</td></tr><tr><td></td><td>RHD</td><td>PF00554</td></tr><tr><td></td><td>DUF291</td><td>PF03442</td></tr><tr><td></td><td>Filamin</td><td>PF00630</td></tr><tr><td></td><td>He_Pig</td><td>PF05345</td></tr><tr><td>Fibronectin type 3</td><td>FN3</td><td>PF00041</td></tr><tr><td></td><td>tissue_fac</td><td>PF01108</td></tr><tr><td></td><td>lep_receptor_Ig</td><td>PF06328</td></tr><tr><td>PKD</td><td>PKD</td><td>PF00801</td></tr><tr><td></td><td>PPC</td><td>PF04151</td></tr><tr><td></td><td>HYR</td><td>PF02494</td></tr><tr><td>&#946;-Galactosidase/&#946;-Glucuronidase</td><td>Glycol_hydro_2</td><td>PF00703</td></tr><tr><td>Cu, Zn Superoxide dismutase-like</td><td>Sod_Cu</td><td>PF00080</td></tr><tr><td>PapD-like</td><td>Pili_assembly_C</td><td>PF02753</td></tr><tr><td></td><td>pili_assembly_N</td><td>PF00345</td></tr><tr><td>Invasin/intimin cell-adhesion fragments</td><td>Big_1</td><td>PF02369</td></tr><tr><td></td><td>Big_2</td><td>PF02368</td></tr><tr><td></td><td>Big_3</td><td>PF07523</td></tr><tr><td></td><td>Big_4</td><td>PF07532</td></tr><tr><td>Clathirin adaptor appendage domain</td><td>Alpha_adaptin_C2</td><td>PF02883</td></tr><tr><td>Transglutaminase N-terminal domain</td><td>Transglut_N</td><td>PF00868</td></tr><tr><td>Cadherin-Like</td><td>Cadherin domain</td><td>PF00028</td></tr><tr><td>Actinoxanthin-like</td><td>Neocarzinostatin family</td><td>PF00960</td></tr><tr><td>CBD9-like</td><td>Domain of unknown function</td><td>PF06452</td></tr><tr><td>laminA/C globular tail domain</td><td>Intermediate filament tail domain</td><td>PF00932</td></tr><tr><td>Other Ig-like</td><td>C type Lectin</td><td>PF00059</td></tr><tr><td></td><td>BACON</td><td>PF13004</td></tr><tr><td></td><td>MucBP</td><td>PF06458</td></tr></table>
dfeb055a062223b015f8664570af37be6cf1d57b895489c0fe3b56478d7b3d0c.png
simple
<table><tr><td>Condition</td><td>Peak moment [(N&#183;m)/kg]</td><td>Peak power (W/kg)</td></tr><tr><td>Unpowered</td><td>1.81 (0.25)</td><td>4.35 (1.10)</td></tr><tr><td>80% extension</td><td>1.65 (0.27)</td><td>3.96 (1.11)</td></tr><tr><td>90% extension</td><td>1.58 (0.52)</td><td>3.94 (1.83)</td></tr><tr><td>0% extension</td><td>1.64 (0.25)</td><td>3.34 (1.29)</td></tr><tr><td>10% extension</td><td>1.65 (0.35)</td><td>3.92 (1.26)</td></tr><tr><td>30% flexion</td><td>1.73 (0.33)</td><td>4.54 (1.01)</td></tr><tr><td>40% flexion</td><td>1.61 (0.27)</td><td>3.68 (1.11)</td></tr><tr><td>50% flexion</td><td>1.71 (0.22)</td><td>3.36 (0.63)</td></tr><tr><td>60% flexion</td><td>1.56 (0.26)</td><td>3.83 (0.87)</td></tr></table>
f98b76df77b9acd7550d1258357c16f41f5a0543901a69d9d57bf53692209e3f.png
complex
<table><tr><td colspan="2">Access to PC dimension</td><td>Number of patients (share)</td><td>Mean(sd)</td></tr><tr><td rowspan="7">Communicational (N=1,943)</td><td>0 = bad access</td><td>3 (0.2%)</td><td rowspan="7">5.548 (0.888)</td></tr><tr><td>1</td><td>18 (0.9%)</td></tr><tr><td>2</td><td>17 (0.9%)</td></tr><tr><td>3</td><td>29 (1.5%)</td></tr><tr><td>4</td><td>111 (5.7%)</td></tr><tr><td>5</td><td>393 (20.2%)</td></tr><tr><td>6 = good access*</td><td>1,372 (70.6%)</td></tr><tr><td rowspan="5">Cultural (N=1,593)</td><td>0 = bad access</td><td>3 (0.2%)</td><td rowspan="5">3.930 (0.356)</td></tr><tr><td>1</td><td>4 (0.3%)</td></tr><tr><td>2</td><td>19 (1.2%)</td></tr><tr><td>3</td><td>49 (3.1%)</td></tr><tr><td>4 = good access*</td><td>1,518 (95.3%)</td></tr><tr><td rowspan="3">Financial (N=1,928)</td><td>0 = bad access</td><td>1 (0.1%)</td><td rowspan="3">1.992 (0.094)</td></tr><tr><td>1</td><td>13 (0.7%)</td></tr><tr><td>2 = good access*</td><td>1,914 (99.3%)</td></tr><tr><td rowspan="3">Geographical (N=1,874)</td><td>0 = bad access</td><td>50 (2.7%)</td><td rowspan="3">1.860 (0.417)</td></tr><tr><td>1</td><td>163 (8.7%)</td></tr><tr><td>2 = good access*</td><td>1,661 (88.6%)</td></tr><tr><td rowspan="5">Organizational (N=1,292)</td><td>0 = bad access</td><td>5 (0.4%)</td><td rowspan="5">3.543 (0.732)</td></tr><tr><td>1</td><td>21 (1.6%)</td></tr><tr><td>2</td><td>93 (7.2%)</td></tr><tr><td>3</td><td>322 (24.9%)</td></tr><tr><td>4 = good access*</td><td>851 (65.9%)</td></tr></table>
0373afdba42f574beb531a4fb84f1ac6d1614bcf2681771fd33f92431aa85ff3.png
complex
<table><tr><td rowspan="2">Variable</td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td><i>r</i></td><td><i>p</i></td><td><i>r</i></td><td><i>p</i></td></tr><tr><td>Weight (kg)</td><td>0.45</td><td>&lt;0.01</td><td>0.36</td><td>&lt;0.01</td></tr><tr><td>Waist circumference (cm)</td><td>0.40</td><td>&lt;0.01</td><td>0.40</td><td>&lt;0.01</td></tr><tr><td>Hip circumference (cm)</td><td>0.37</td><td>&lt;0.01</td><td>0.33</td><td>&lt;0.01</td></tr><tr><td>Waist to hip ratio</td><td>0.05</td><td>0.18</td><td>0.22</td><td>&lt;0.01</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>0.41</td><td>&lt;0.01</td><td>0.30</td><td>&lt;0.01</td></tr><tr><td>SBP (mmHg)</td><td>0.18</td><td>&lt;0.01</td><td>0.08</td><td>&lt;0.01</td></tr><tr><td>DBP (mmHg)</td><td>0.09</td><td>&lt;0.01</td><td>0.06</td><td>&lt;0.01</td></tr><tr><td>FBG (mmol/L)</td><td>0.06</td><td>0.09</td><td>0.10</td><td>&lt;0.01</td></tr><tr><td>Fasting insulin (pmol/L)</td><td>0.11</td><td>&lt;0.01</td><td>0.09</td><td>&lt;0.01</td></tr><tr><td>HbA1c (%)</td><td>0.11</td><td>&lt;0.01</td><td>0.06</td><td>&lt;0.01</td></tr><tr><td>HOMA-IR</td><td>0.12</td><td>&lt;0.01</td><td>0.17</td><td>&lt;0.01</td></tr><tr><td>Total cholerterol (mmol/L)</td><td>0.10</td><td>&lt;0.01</td><td>0.02</td><td>0.51</td></tr><tr><td>LDL-cholesterol (mmol/L)</td><td>0.16</td><td>&lt;0.01</td><td>0.01</td><td>0.57</td></tr><tr><td>HDL-cholesterol (mmol/L)</td><td>&#8722;0.13</td><td>&lt;0.01</td><td>&#8722;0.18</td><td>&lt;0.01</td></tr><tr><td>Triglycerides (mmol/L)</td><td>0.14</td><td>&lt;0.01</td><td>0.14</td><td>&lt;0.01</td></tr><tr><td>Creatinine (umol/L)</td><td>0.11</td><td>&lt;0.01</td><td>0.05</td><td>0.05</td></tr><tr><td>eGFR (ml/min/1.73<sup>2</sup>)</td><td>&#8722;0.13</td><td>&lt;0.01</td><td>0.07</td><td>&lt;0.01</td></tr><tr><td>ALT (U/L)</td><td>0.07</td><td>0.05</td><td>0.07</td><td>&lt;0.01</td></tr></table>
b47d0aa747349dd091a65dd58ff556d44b79e978153e2c069aa7aff575a80f4f.png
complex
<table><tr><td></td><td>Total weight change over 17 days compared to control/% change</td><td>Daily weight change (per day over 17 days) compared to control (kg)</td></tr><tr><td colspan="3">Treatment 1 - Control</td></tr><tr><td>Treatment 2&#8211;0.5&#215;</td><td>0.633 kg/11.1%</td><td>0.037 kg</td></tr><tr><td>Treatment 3 - lx</td><td>&#8722;0.325 kg/&#8722;5.7%</td><td>&#8722;0.019 kg</td></tr><tr><td>Treatment 4 - 2&#215;</td><td>0.807 kg/14.1%</td><td>0.047 kg</td></tr></table>
b8f19374a78ec687e0e07eb3c8f96a4f843f82c5d692751383e1d1d5b3e78116.png
complex
<table><tr><td rowspan="3">Key obstetric danger signs</td><td colspan="2">Place of delivery</td><td rowspan="3"><i>P</i>-values*</td></tr><tr><td>Cases (<i>n</i> = 118)</td><td>Controls (<i>n</i> = 238)</td></tr><tr><td>Frequency (%)</td><td>Frequency (%)</td></tr><tr><td>Key danger sign during pregnancy</td><td></td><td></td><td></td></tr><tr><td>Vaginal bleeding</td><td>86(72.9)</td><td>117(49.2)</td><td>&lt;0.001</td></tr><tr><td>Swelling of the face and hands</td><td>56(47.5)</td><td>35(14.7)</td><td>&lt;0.001</td></tr><tr><td>Blurring (difficult) vision</td><td>26(22.0)</td><td>26(10.9)</td><td>0.005</td></tr><tr><td>Key danger sign during Labour and delivery</td><td></td><td></td><td></td></tr><tr><td>Excess vaginal bleeding</td><td>93(78.8)</td><td>89(37.4)</td><td>&lt;0.001</td></tr><tr><td>Prolonged labour (&gt;12 hours)</td><td>76(64.4)</td><td>113(47.5)</td><td>0.003</td></tr><tr><td>Retained placenta(&gt;30minuts)</td><td>54(45.8)</td><td>74(31.1)</td><td>0.007</td></tr><tr><td>Convulsions</td><td>13(11.0)</td><td>2(0.8)</td><td>&lt;0.001</td></tr><tr><td>Key danger sign during postpartum period</td><td></td><td></td><td></td></tr><tr><td>Vaginal bleeding</td><td>71(60.2)</td><td>76(31.9)</td><td>&lt;0.001</td></tr><tr><td>Increased body temp (fever)</td><td>8(6.8)</td><td>11(4.6)</td><td>0.454</td></tr><tr><td>Offensive vaginal bleeding</td><td>21(17.8)</td><td>13(5.5)</td><td>&lt;0.001</td></tr></table>
f14fd277dc69438a156eee6bec8fb4513d9f96682d49014111d74dcef93c7f30.png
complex
<table><tr><td></td><td>Bipolar disorder</td><td>Depression</td><td></td><td>Non-mood disorder</td><td></td></tr><tr><td></td><td>(n = 572)</td><td>(n = 5,464)</td><td></td><td>(n = 53,905)</td><td></td></tr><tr><td>Total U.S. Population(18-64)</td><td>1,647,408</td><td>16,874,994</td><td></td><td>165,702,423</td><td></td></tr><tr><td></td><td>0.9%</td><td>9.2%</td><td></td><td>90.0%</td><td></td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>35.2%</td><td>33.3%</td><td></td><td>51.1%</td><td>*</td></tr><tr><td>Female</td><td>64.8%</td><td>66.7%</td><td></td><td>48.9%</td><td>*</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>18-24</td><td>11.4%</td><td>9.7%</td><td></td><td>16.1%</td><td>*</td></tr><tr><td>25-34</td><td>20.7%</td><td>16.2%</td><td></td><td>22.0%</td><td></td></tr><tr><td>35-44</td><td>30.3%</td><td>23.0%</td><td>*</td><td>23.1%</td><td>*</td></tr><tr><td>45-54</td><td>25.1%</td><td>28.8%</td><td></td><td>22.3%</td><td></td></tr><tr><td>55-64</td><td>12.5%</td><td>22.3%</td><td>*</td><td>16.6%</td><td>*</td></tr><tr><td>Race/Ethnicity</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Hispanic</td><td>8.1%</td><td>9.4%</td><td></td><td>14.8%</td><td>*</td></tr><tr><td>NH White</td><td>74.3%</td><td>77.9%</td><td></td><td>65.8%</td><td>*</td></tr><tr><td>NH Black</td><td>9.2%</td><td>7.8%</td><td></td><td>12.3%</td><td></td></tr><tr><td>NH Multiple</td><td>4.7%</td><td>2.4%</td><td></td><td>1.2%</td><td>*</td></tr><tr><td>NH Other</td><td>3.8%</td><td>2.5%</td><td></td><td>6.0%</td><td></td></tr><tr><td>Marital status</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Married</td><td>35.8%</td><td>48.1%</td><td>*</td><td>56.3%</td><td>*</td></tr><tr><td>Other</td><td>64.2%</td><td>51.9%</td><td>*</td><td>43.8%</td><td>*</td></tr><tr><td colspan="5">Income (% Federal Poverty Level)</td><td></td></tr><tr><td>&lt; 200%</td><td>39.0%</td><td>21.3%</td><td>*</td><td>13.5%</td><td>*</td></tr><tr><td>200-399%</td><td>39.3%</td><td>43.4%</td><td></td><td>43.4%</td><td></td></tr><tr><td>&gt; = 400%</td><td>21.7%</td><td>35.4%</td><td>*</td><td>43.1%</td><td>*</td></tr><tr><td colspan="5">Educational Attainment (24 and older)</td><td></td></tr><tr><td>Less than High School grad</td><td>16.6%</td><td>15.9%</td><td></td><td>14.3%</td><td></td></tr><tr><td>High School grad</td><td>35.7%</td><td>31.9%</td><td></td><td>30.9%</td><td></td></tr><tr><td>Some College</td><td>27.1%</td><td>24.7%</td><td></td><td>23.3%</td><td></td></tr><tr><td>College degree or more</td><td>20.7%</td><td>27.4%</td><td>*</td><td>31.5%</td><td>*</td></tr><tr><td>Living Arrangement</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Living Alone</td><td>37.6%</td><td>25.6%</td><td>*</td><td>17.1%</td><td>*</td></tr><tr><td>Living with child and adult</td><td>24.5%</td><td>29.0%</td><td></td><td>40.3%</td><td>*</td></tr><tr><td>Living with adult only</td><td>29.4%</td><td>38.2%</td><td>*</td><td>38.4%</td><td>*</td></tr><tr><td>Living with child only</td><td>8.5%</td><td>7.2%</td><td></td><td>4.2%</td><td>*</td></tr><tr><td>Comorbid conditions</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>0</td><td>78.8%</td><td>74.9%</td><td></td><td>88.3%</td><td>*</td></tr><tr><td>1</td><td>16.9%</td><td>19.5%</td><td></td><td>10.3%</td><td>*</td></tr><tr><td>2</td><td>2.9%</td><td>4.6%</td><td></td><td>1.2%</td><td></td></tr><tr><td>3 or more</td><td>1.4%</td><td>1.1%</td><td></td><td>0.2%</td><td></td></tr><tr><td>Geography</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Metropolitan Statistical Area (MSA)</td><td>19.9%</td><td>17.5%</td><td></td><td>16.1%</td><td></td></tr><tr><td>Non-MSA</td><td>80.1%</td><td>82.5%</td><td></td><td>83.9%</td><td></td></tr><tr><td>Region</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Northeast</td><td>18.8%</td><td>16.6%</td><td></td><td>18.7%</td><td></td></tr><tr><td>Midwest</td><td>25.3%</td><td>25.6%</td><td></td><td>21.9%</td><td></td></tr><tr><td>South</td><td>32.1%</td><td>33.9%</td><td></td><td>36.3%</td><td></td></tr><tr><td>West</td><td>23.8%</td><td>23.9%</td><td></td><td>23.1%</td><td></td></tr></table>
906397197f44b5a43c3c5bc86b6c1b86975fb1a1edb296a55ae4a1c4b1e3add6.png
simple
<table><tr><td><i>Trait category</i></td><td><i>Traits from GWAS consortia</i></td><td>r<sub><i>g</i></sub></td><td><i>s.e.</i></td><td>P</td></tr><tr><td>Physical health</td><td>Blood pressure: diastolic</td><td>0.0332</td><td>0.0502</td><td>0.5083</td></tr><tr><td> </td><td>Blood pressure: systolic</td><td>&#8722;0.0698</td><td>0.0478</td><td>0.1444</td></tr><tr><td> </td><td>BMI</td><td>0.2024</td><td>0.0322</td><td>3.18 &#215; 10<sup>&#8722;10</sup></td></tr><tr><td> </td><td>Cholesterol: HDL</td><td>&#8722;0.1087</td><td>0.0373</td><td>0.0036</td></tr><tr><td> </td><td>Cholesterol: LDL</td><td>0.0829</td><td>0.0413</td><td>0.0449</td></tr><tr><td> </td><td>Coronary artery disease</td><td>0.1338</td><td>0.067</td><td>0.0459</td></tr><tr><td> </td><td>C-reactive protein</td><td>0.0165</td><td>0.054</td><td>0.0021</td></tr><tr><td> </td><td>Grip strengtha</td><td>&#8722;0.1596</td><td>0.0482</td><td>0.0009</td></tr><tr><td> </td><td>HbA1c</td><td>0.2536</td><td>0.0857</td><td>0.0031</td></tr><tr><td> </td><td>Height</td><td>&#8722;0.0201</td><td>0.0297</td><td>0.4980</td></tr><tr><td> </td><td>Longevity</td><td>&#8722;0.3943</td><td>0.1096</td><td>0.0003</td></tr><tr><td> </td><td>Forced expiratory volume 1sa</td><td>&#8722;0.1181</td><td>0.0538</td><td>0.0281</td></tr><tr><td> </td><td>Obesity</td><td>0.2063</td><td>0.0381</td><td>6.31 &#215; 10<sup>&#8722;8</sup></td></tr><tr><td> </td><td>Rheumatoid arthritis</td><td>&#8722;0.0181</td><td>0.0674</td><td>0.7885</td></tr><tr><td> </td><td>Self-rated healtha</td><td>&#8722;0.7780</td><td>0.0349</td><td>7.30 &#215; 10<sup>&#8722;110</sup></td></tr><tr><td> </td><td>Smoking status</td><td>0.2009</td><td>0.0603</td><td>0.0009</td></tr><tr><td> </td><td>Triglycerides</td><td>0.1324</td><td>0.0332</td><td>6.62 &#215; 10<sup>&#8722;5</sup></td></tr><tr><td> </td><td>Type 2 diabetes</td><td>0.1784</td><td>0.0689</td><td>0.0097</td></tr><tr><td> </td><td>Waist&#8211;hip ratio</td><td>0.2834</td><td>0.0417</td><td>1.09 &#215; 10<sup>&#8722;11</sup></td></tr><tr><td>Mental health</td><td>ADHD</td><td>0.2694</td><td>0.1116</td><td>0.0158</td></tr><tr><td> </td><td>Alzheimer&#8217;s disease</td><td>0.0762</td><td>0.1079</td><td>0.4801</td></tr><tr><td> </td><td>Alzheimer&#8217;s disease (500 kb)</td><td>0.0613</td><td>0.0872</td><td>0.4816</td></tr><tr><td> </td><td>Anorexia nervosa</td><td>0.0192</td><td>0.0492</td><td>0.6967</td></tr><tr><td> </td><td>Autism</td><td>0.0129</td><td>0.0695</td><td>0.8522</td></tr><tr><td> </td><td>Bipolar disorder</td><td>0.1382</td><td>0.0605</td><td>0.0223</td></tr><tr><td> </td><td>Childhood cognitive ability</td><td>&#8722;0.1528</td><td>0.0891</td><td>0.0864</td></tr><tr><td> </td><td>Major depressive disorder</td><td>0.5902</td><td>0.1015</td><td>6.03 &#215; 10<sup>&#8722;9</sup></td></tr><tr><td> </td><td>Neuroticism</td><td>0.6150</td><td>0.038</td><td>7.34 &#215; 10<sup>&#8722;59</sup></td></tr><tr><td> </td><td>Schizophrenia</td><td>0.2490</td><td>0.0386</td><td>1.14 &#215; 10<sup>&#8722;10</sup></td></tr><tr><td> </td><td>Verbal-numerical reasoninga</td><td>&#8722;0.1379</td><td>0.0596</td><td>0.0206</td></tr></table>
9f36d8b0141cfa7d0a297dbbc665825b38f17ce9ebe0c1ca0f54e8ad721b7577.png
simple
<table><tr><td>Average number of antenatal visits</td><td>Average number in intervention arm</td><td>Difference</td><td>Power</td><td>Sample sizeper arm</td></tr><tr><td>8.9</td><td>10.9</td><td>2</td><td>90%</td><td>190</td></tr><tr><td>9.4</td><td>10.9</td><td>1.5</td><td>90%</td><td>337</td></tr></table>
dce84ac86fdbd2489fad25f88d5c470eebfb8ef3b05b6191745018d0e47237af.png
simple
<table><tr><td>2001 NCEP ATP III definition</td><td>AHA/NHLBI definition</td><td>IDF definition</td></tr><tr><td>(any three of five)</td><td>(any three of five)</td><td>(required<sup>a</sup>and any two of four criteria left)</td></tr><tr><td>BMI &#8805;30 kg/m<sup>2</sup></td><td>BMI &#8805; 30 kg/m<sup>2</sup></td><td>BMI &#8805;30 kg/m<sup>2 a</sup></td></tr><tr><td>TG &#8805;150 mg/dl</td><td>TG &#8805;150 mg/dl or treatment for elevated TG</td><td>TG &#8805;150 mg/dl or treatment for elevated TG</td></tr><tr><td>C-HDL &lt;40 mg/dl in men</td><td>C-HDL &lt;40 mg/dl in men</td><td>C-HDL &lt;40 mg/dl in men</td></tr><tr><td>C-HDL &lt;50 mg/dl in women</td><td>C-HDL &lt;50 mg/dl in women</td><td>C-HDL &lt;50 mg/dl in women</td></tr><tr><td>Blood pressure &#8805;130/85 mmHg or previous hypertension diagnosis</td><td>Blood pressure &#8805;130/85 mmHg or previous hypertension diagnosis</td><td>Blood pressure &#8805;130/85 mmHg or previous hypertension diagnosis</td></tr><tr><td>Fasting glucose &#8805;110 mg/dl or previous type 2 DM</td><td>Fasting glucose &#8805;100 mg/dl or previous type 2 DM</td><td>Fasting glucose &#8805;100 mg/dl or previous type 2 DM</td></tr></table>
5ded953d0ac58a6fdb372f55ccb04e2672fa98ae0928266bb3e0b1b0bb626856.png
simple
<table><tr><td>Metastasis location</td><td>Upper thoracic section (174)</td><td>Middle thoracic section (132)</td><td>Lower thoracic section (80)</td><td>Total</td><td><i>P</i></td></tr><tr><td>CTG zone</td><td>117(67.2%)</td><td>50(37.9%)</td><td>15(18.8%)</td><td>182(47.2%)</td><td>0.000</td></tr><tr><td>MSC zone</td><td>55(31.6%)</td><td>25(18.9%)</td><td>9(11.3%)</td><td>89(23.1%)</td><td>0.001</td></tr><tr><td>LSC zone</td><td>11(6.3%)</td><td>4(3.0%)</td><td>1(1.3%)</td><td>16(4.1%)</td><td>0.124</td></tr></table>
d609bc7ac3512922655b61f9ebc5f779e792abe620c62ab8c9d4c5a7b67d4605.png
simple
<table><tr><td></td><td>No toxicity</td><td>Grade 1</td><td>Grade 2</td><td>Grade 3</td><td>Grade 4</td></tr><tr><td>Dyesthesia</td><td>12.8%</td><td>70.9%</td><td>11.6%</td><td>4.7%</td><td>0%</td></tr><tr><td>Paresthesia</td><td>5.7%</td><td>66.3%</td><td>19.8%</td><td>7%</td><td>1.2%</td></tr></table>
765207991349f855d4bf98f43942567bf1ffadec57d96eda1e9446588accdb11.png
complex
<table><tr><td></td><td>Categories</td><td>Number (%)</td></tr><tr><td rowspan="6">Age range (years)</td><td>2&#8211;4</td><td>2 (3%)</td></tr><tr><td>4&#8211;12</td><td>19 (28%)</td></tr><tr><td>12&#8211;19</td><td>22 (33%)</td></tr><tr><td>19&#8211;40</td><td>18 (27%)</td></tr><tr><td>40&#8211;50</td><td>3 (4.5%)</td></tr><tr><td>&gt;50</td><td>3 (4.5%)</td></tr><tr><td rowspan="6">Type of abnormal foot position</td><td>Equinus</td><td>18 (27%)</td></tr><tr><td>Flatfoot (flexible)</td><td>15 (22%)</td></tr><tr><td>Flatfoot (rigid)</td><td>12 (18%)</td></tr><tr><td>Other</td><td>7 (10.5%)</td></tr><tr><td>No problems</td><td>10 (15%)</td></tr><tr><td>Nil response</td><td>5 (7.5%)</td></tr><tr><td rowspan="6">Type of foot support</td><td>Semi-orthopedic footwear</td><td>14 (21%)</td></tr><tr><td>Orthopedic footwear</td><td>17 (25.5%)</td></tr><tr><td>Ankle-foot orthosis (AFO)</td><td>15 (22%)</td></tr><tr><td>Other</td><td>4 (6%)</td></tr><tr><td>Not required</td><td>10 (15%)</td></tr><tr><td>Nil response</td><td>7 (10.5%)</td></tr><tr><td rowspan="4">Full foot on the floor (when standing with bare feet)</td><td>Yes</td><td>24 (36%)</td></tr><tr><td>Partial</td><td>4 (6%)</td></tr><tr><td>No</td><td>30 (45%)</td></tr><tr><td>Nil response</td><td>9 (13%)</td></tr><tr><td rowspan="3">Symmetrical weight bearing through both legs (when standing)</td><td>Yes</td><td>12 (18%)</td></tr><tr><td>No</td><td>46 (69%)</td></tr><tr><td>Nil response</td><td>9 (13%)</td></tr></table>
98f79e757770c703b0280ff27b7524d4c1b4718c86d43ade2a10077fe3bacd2a.png
simple
<table><tr><td> </td><td>Subj.</td><td>Resp.</td><td>Resp. Ad.</td><td>Heart</td><td>Heart Ad.</td></tr><tr><td> </td><td> </td><td>[min<sup>&#8722;1</sup>]</td><td>[min<sup>&#8722;1</sup>]</td><td>[bpm]</td><td>[bpm]</td></tr><tr><td>SE</td><td>1</td><td>0.0 (0.3)</td><td>0.0 (0.3)</td><td>-0.3 (2.1)</td><td>-0.2 (1.4)</td></tr><tr><td>SE</td><td>2</td><td>-0.3 (0.5)</td><td>-0.2 (0.3)</td><td>-0.8 (2.3)</td><td>-0.7 (1.7)</td></tr><tr><td>DS</td><td>1</td><td>-0.1 (0.3)</td><td>0.0 (0.3)</td><td>-1.2 (2.3)</td><td>-0.2 (1.5)</td></tr><tr><td>DS</td><td>2</td><td>-0.3 (0.4)</td><td>-0.2 (0.3)</td><td>-0.3 (2.2)</td><td>-0.8 (1.7)</td></tr><tr><td>BS</td><td>1</td><td>-0.1 (0.2)</td><td>0.0 (0.3)</td><td>11.2 (5.7)</td><td>-0.2 (1.5)</td></tr><tr><td>BS</td><td>2</td><td>-0.2 (0.4)</td><td>-0.2 (0.3)</td><td>42.0 (6.1)</td><td>-0.7 (1.7)</td></tr></table>
cd77de12ca020c898d6d21d08d3130fa021f39c18f342a4076efd6789d42976c.png
simple
<table><tr><td>Cell line</td><td>HPV DNA</td><td>Cisplatin IC<sub>50</sub> (&#956;mol/L)</td></tr><tr><td>UPCI-SCC-003</td><td>(&#8722;)</td><td>1.7</td></tr><tr><td>UPCI-SCC-036</td><td>(&#8722;)</td><td>3.0</td></tr><tr><td>UPCI-SCC-089</td><td>(&#8722;)</td><td>1.2</td></tr><tr><td>UPCI-SCC-090</td><td>(+)</td><td>5.7</td></tr><tr><td>UPCI-SCC-152</td><td>(+)</td><td>4.6</td></tr><tr><td>UPCI-SCC-154</td><td>(+)</td><td>2.0</td></tr></table>
81559c030fcc3ac02d5cfea7c88d5037f13b392fcec88b6a88c7e5d283a71ca8.png
simple
<table><tr><td>Patient</td><td>Pre-operative cretinine</td><td>Post-operative creatinine</td><td>Voiding</td><td>Incontience</td><td>Dialysis</td></tr><tr><td>1</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr><tr><td>2</td><td>Elevated</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr><tr><td>3</td><td>Elevated</td><td>Elevated</td><td>Vesicostomy</td><td>&#8722;</td><td>+</td></tr><tr><td>4</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr><tr><td>5</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr><tr><td>6</td><td>Elevated</td><td>Elevated</td><td>CIC</td><td>&#8722;</td><td>+</td></tr><tr><td>7</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr><tr><td>8</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr><tr><td>9</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>Frequency/urgency</td><td>&#8722;</td></tr><tr><td>10</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr><tr><td>11</td><td>Normal</td><td>Normal</td><td>Spontaneous</td><td>&#8722;</td><td>&#8722;</td></tr></table>
0907eb0d12553d859177880a6cd9b5168b48d843c97f20fc35361bcca9ff34da.png
complex
<table><tr><td>Cell line</td><td colspan="3">HEK 293T</td><td colspan="3">HeLa</td></tr><tr><td>Replicate number</td><td>1</td><td>2</td><td>3</td><td>1</td><td>2</td><td>3</td></tr><tr><td>Telomerase activity ratio (flow through/input)</td><td>0.65</td><td>0.48</td><td>0.44</td><td>0.56</td><td>0.37</td><td>0.33</td></tr><tr><td>hTR ratio (flow through/input)</td><td>0.94</td><td>0.84</td><td>0.77</td><td>0.91</td><td>0.88</td><td>0.88</td></tr><tr><td>Estimated number of assembled telomerase monomer per cell<sup>a</sup></td><td>146</td><td>245</td><td>332</td><td>255</td><td>255</td><td>222</td></tr><tr><td>Million hTR per &#956;l elution<sup>b</sup></td><td>9.2</td><td>8.2</td><td></td><td>1.2</td><td>1.3</td><td>1.4</td></tr><tr><td>Million hTERT per &#956;l elution</td><td>15</td><td>11</td><td></td><td>1.7</td><td>3.1</td><td>3.3</td></tr><tr><td>Estimated number of hTERT protein per cell<sup>c</sup></td><td>237</td><td>322</td><td></td><td>382</td><td>608</td><td>534</td></tr></table>
88f6b6fca96bd48305c99e07d1388106cd7f8b74b9100e470c95f38cbeec29c5.png
simple
<table><tr><td>Authors</td><td>Number of patients/centres included</td><td>Epoetin isoform</td><td>Variables explored (inputs)</td><td>Predictions (outputs)</td></tr><tr><td><i>Gabutti et al </i>(present study)</td><td>432/29</td><td>Beta</td><td>Sex; age; weight, presence or absence of a diabetes mellitus and/or a cardiomyopathy with EF&lt;50%; haemoglobin; creatinine; BUN; pH; ionized calcium; albumin; CRP; ferritin; PTH; epoetin and iron dose; epoetin administration route sc vs. iv; Kt/V</td><td>Epoetin dose and follow-up haemoglobin</td></tr><tr><td><i>Bellazzi </i>[24]</td><td>10/1</td><td>n.s.</td><td>Sex; age; haemoglobin; calcium; PTH; epoetin dose and others non specified</td><td>Follow-up haemoglobin</td></tr><tr><td><i>Martin Guerriero et al </i>[20]</td><td>110/1</td><td>Alpha and beta</td><td>Age; weight; haemoglobin; ferritin; epoetin dose; isoform and number of administrations weekly; iron dose</td><td>Epoetin dose</td></tr><tr><td><i>Gaweda et al </i>[25]</td><td>209/1</td><td>n.s.</td><td>Haematocrit; albumin; ferritin; iron saturation; PTH; epoetin and iron dose; Kt/V</td><td>Follow-up haematocrit</td></tr><tr><td><i>Jacobs et al </i>[26]</td><td>166/n.s.</td><td>n.s.</td><td>Haematocrit; albumin; ferritin; iron saturation; PTH; epoetin and iron dose; Kt/V</td><td>Follow-up haematocrit</td></tr></table>
7e489178445216cd2c01d6048a37a99a0e7845e23c09aaa95df84a705265dd53.png
simple
<table><tr><td>Maryland score</td><td>Mean &#177; SD</td><td>Excellent (%) (90&#8211;100)</td><td>Good (%) (75&#8211;89)</td><td>Fair (%) (50&#8211;74)</td><td>Poor (&lt;50)</td></tr><tr><td>Total</td><td>88.1 &#177; 8.8</td><td>11 (61.1)</td><td>4 (22.2)</td><td>3 (16.7)</td><td>0 (0)</td></tr><tr><td>Sanders II</td><td>88.1 &#177; 8.8</td><td>8 (57.1)</td><td>4 (28.6)</td><td>2 (14.3)</td><td>0 (0)</td></tr><tr><td>Sanders III</td><td>87.8 &#177; 10.1</td><td>3 (75.0)</td><td>0 (0)</td><td>1 (25.0)</td><td>0 (0)</td></tr></table>
bc20cfcbda07805d498584c3217fd2dcd51701711038fb716ea0cf338979b2fe.png
simple
<table><tr><td></td><td>IORNS SRI r</td><td>IORNS DRI r</td><td>IORNS PSI r</td><td>IORNS TOT r</td></tr><tr><td>LASC severity</td><td>.22</td><td>.40**</td><td>&#8722;.16</td><td>.33</td></tr><tr><td>LASC global</td><td>.25</td><td>.56**</td><td>&#8722;.34*</td><td>.52**</td></tr><tr><td>LASC B &#8220;re-experiencing&#8221;</td><td>.09</td><td>.29</td><td>&#8722;.18</td><td>.21</td></tr><tr><td>LASC C &#8220;avoidance&#8221;</td><td>.25</td><td>.46**</td><td>&#8722;.11</td><td>.43**</td></tr><tr><td>LASC D &#8220;hyperarousal&#8221;</td><td>.15</td><td>.28</td><td>&#8722;.11</td><td>.23</td></tr></table>
f20fbb483ede01f5adad541ab22cbe08db15d96167706b8f7610d7fdd9c303b4.png
complex
<table><tr><td>Urban Area</td><td>Type of Mobile Source Pollution</td><td>EC</td><td>NO<sub>x</sub></td><td>CO</td></tr><tr><td rowspan="3">Atlanta, GA</td><td>Diesel</td><td>0.64</td><td>0.36</td><td>*</td></tr><tr><td>Gasoline</td><td>*</td><td>0.38</td><td>0.62</td></tr><tr><td>Combined</td><td>0.32</td><td>0.36</td><td>0.32</td></tr><tr><td rowspan="3">Denver, CO</td><td>Diesel</td><td>0.70</td><td>0.30</td><td>*</td></tr><tr><td>Gasoline</td><td>*</td><td>0.32</td><td>0.68</td></tr><tr><td>Combined</td><td>0.33</td><td>0.29</td><td>0.37</td></tr><tr><td rowspan="3">Houston, TX</td><td>Diesel</td><td>0.55</td><td>0.44</td><td>*</td></tr><tr><td>Gasoline</td><td>*</td><td>0.35</td><td>0.65</td></tr><tr><td>Combined</td><td>0.22</td><td>0.38</td><td>0.40</td></tr></table>
e05e08fe9f29ddacc0b4892a71161a0d8a6b289e7f45b28d0badac2eb391f197.png
simple
<table><tr><td>Parameter</td><td>Ethnic group</td><td>Rest of the sample</td><td>P value</td></tr><tr><td>Age (years&#177; standard deviation)</td><td>39.5&#177;14</td><td>39.1&#177;13</td><td>NS</td></tr><tr><td>Gender</td><td></td><td></td><td></td></tr><tr><td>% Female</td><td>51.5</td><td>58</td><td>NS</td></tr><tr><td>% Male</td><td>48.5</td><td>42</td><td>NS</td></tr><tr><td>Education level</td><td></td><td></td><td></td></tr><tr><td>% Without studies or elementary school</td><td>48.9</td><td>44.8</td><td>&lt;0.05</td></tr><tr><td>% High-school</td><td>43.4</td><td>46.7</td><td>&lt;0.05</td></tr><tr><td>% College</td><td>7.7</td><td>8.5</td><td>NS</td></tr><tr><td>% Self-reported gingival bleeding</td><td>5.1</td><td>3.4</td><td>&lt;0.05</td></tr><tr><td>GDP</td><td>0.63</td><td>0.70</td><td>&lt;0.05</td></tr><tr><td>HDI</td><td>0.75</td><td>0.78</td><td>&lt;0.05</td></tr><tr><td>UBNI</td><td>32</td><td>20.7</td><td>&lt;0.05</td></tr></table>
6e6f2d39042616d2b931972a41a4b464271d3bb4c40aa1ff7b2c8567fa59d9af.png
complex
<table><tr><td rowspan="2">ZMP</td><td>Fore-aft</td><td>Lateral</td></tr><tr><td>Std.</td><td>Std.</td></tr><tr><td>Open-loop</td><td>21.1 mm</td><td>14.9 mm</td></tr><tr><td>Closed-loop</td><td>12.1 mm</td><td>14.1 mm</td></tr></table>
0d13af0e03e058f9b8f77ce28a6184c4be42b73c3bac94c759120b334b721392.png
simple
<table><tr><td>GO Term</td><td>Annotation</td><td>Abbreviation</td></tr><tr><td>GO:0006281</td><td>DNA repair</td><td>DNA repair</td></tr><tr><td>GO:0006284</td><td>base-excision repair</td><td>BER</td></tr><tr><td>GO:0006289</td><td>nucleotide-excision repair</td><td>NER</td></tr><tr><td>GO:0006298</td><td>mismatch repair</td><td>MMR</td></tr><tr><td>GO:0000724</td><td>double-strand break repair via homologous recombination</td><td>HR</td></tr><tr><td>GO:0006303</td><td>double-strand break repair via non-homologous end joining</td><td>NHEJ</td></tr></table>
e3478d9452b83f5040e84fe7c3bf833a1e0ca78b92b29fe4f672b0b3813ab1c6.png
complex
<table><tr><td colspan="2">Patient characteristics:</td><td>N</td><td>%</td><td>Median</td><td>Range</td></tr><tr><td colspan="2">All MPS I</td><td>61</td><td></td><td></td><td></td></tr><tr><td></td><td>Gender (male/female)</td><td>38/23</td><td>62/38</td><td></td><td></td></tr><tr><td></td><td>Phenotype (Hurler/Attenuated)</td><td>44/17</td><td>69/31</td><td></td><td></td></tr><tr><td></td><td>Age @ Start of treatment (mths)</td><td></td><td></td><td>18</td><td>3-364</td></tr><tr><td></td><td>Age @ final assessment (mths)</td><td></td><td></td><td>82</td><td>0.3-420</td></tr><tr><td colspan="3">HSCT treated Hurler patient characteristics</td><td></td><td></td><td></td></tr><tr><td></td><td>Gender (male/female)</td><td>30/14</td><td></td><td></td><td></td></tr><tr><td></td><td>Age @ Start of treatment (mths)</td><td></td><td></td><td>14</td><td>3-30</td></tr><tr><td></td><td>Age @ final assessment (mths)</td><td></td><td></td><td>66</td><td>11-203</td></tr><tr><td></td><td>Interventions</td><td></td><td></td><td colspan="2"></td></tr><tr><td></td><td>Therapeutic airway intervention post-HSCT</td><td>3</td><td>7%</td><td colspan="2">Adenotonsillar surgery: 2 pts (1 had revision). Longterm O<sub>2</sub>: 1</td></tr><tr><td></td><td colspan="2">Treatments and metabolic characteristics</td><td></td><td></td><td></td></tr><tr><td></td><td>No HSCT (1/2/3)</td><td>32/8/1</td><td>78/20/2</td><td></td><td></td></tr><tr><td></td><td>Source (CB/BM/PBSC/Unknown)</td><td>17/15/7/2</td><td>41/37/17/5</td><td></td><td></td></tr><tr><td></td><td>Donor (Related/MUD)</td><td>15/26</td><td>37/63</td><td></td><td></td></tr><tr><td></td><td>IDUA @ 1 year post HSCT</td><td>36</td><td></td><td>30.0</td><td>6.3-87.0</td></tr><tr><td></td><td>Heterozygote Donors</td><td>12</td><td></td><td>19.7</td><td>6.7-49.4</td></tr><tr><td></td><td>Matched Unrelated Donors</td><td>24</td><td></td><td>34.6</td><td>17.7-87.0</td></tr><tr><td></td><td>Pre HSCT DS:CS ratio</td><td>20</td><td></td><td>1.6</td><td>0.7-3.4</td></tr><tr><td></td><td>DS:CS ratio @ 1 year</td><td>32</td><td></td><td>0.5</td><td>0.2-0.8</td></tr><tr><td colspan="4">ERT treated Hurler Patients</td><td></td><td></td></tr><tr><td></td><td>Gender (male/female)</td><td>2/1</td><td></td><td></td><td></td></tr><tr><td></td><td>Age @ Start of treatment (mths)</td><td></td><td></td><td>85</td><td>74-144</td></tr><tr><td></td><td>Age @ final assessment (mths)</td><td></td><td></td><td>123</td><td>98-148</td></tr><tr><td colspan="4">ERT Treated attenuated patients</td><td></td><td></td></tr><tr><td></td><td>Gender (male/female)</td><td>9/8</td><td></td><td></td><td></td></tr><tr><td></td><td>Age @ Start of treatment (mths)</td><td></td><td></td><td>60</td><td>24-364</td></tr><tr><td></td><td>Age @ final assessment (mths)</td><td></td><td></td><td>131</td><td>72-420</td></tr><tr><td></td><td>Interventions</td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="2"></td><td rowspan="2">Therapeutic airway intervention on ERT</td><td rowspan="2">7</td><td rowspan="2">41%</td><td colspan="2">CPAP: 5 pts</td></tr><tr><td colspan="2">Adenotonsillar Surgery: 2 pts (1 had revision)</td></tr><tr><td></td><td>Metabolic characteristics</td><td></td><td></td><td colspan="2"></td></tr><tr><td></td><td>Pre ERT DS:CS ratio</td><td>5</td><td></td><td>1.9</td><td>1.1-2.7</td></tr><tr><td></td><td>DS:CS ratio @ 1 year</td><td>13</td><td></td><td>0.8</td><td>0.4-2.2</td></tr></table>
7a05923dea09ecefb98a4cc15594825043dd722a6b9c5405e184871b759f3551.png
simple
<table><tr><td>Position</td><td>Residue (number of independent origins)</td></tr><tr><td>97</td><td>*C (1), F (2), I (4), L (A), V (5), *Y (1)</td></tr><tr><td>100</td><td>A (1), *F (1), *G (1), I (A), *L (1), *T (1), V (4)</td></tr><tr><td>117</td><td>H (1), I (4), L (A), V (1)</td></tr><tr><td>125</td><td>A (A), *C (1), *F (1), I (3), L (2), T (1), V (3)</td></tr><tr><td>135</td><td>I (4), L (A), *T (1), V (2)</td></tr><tr><td>154</td><td>A (1), *C (1), *F (1), I (A), L (2), *M (1), V (5)</td></tr></table>
bfc5bd26cc17301b73eee80e878e33b281351706aa769679efb62a356d6c4e07.png
complex
<table><tr><td rowspan="3">CLOCK genotypes</td><td colspan="9">Non-T2D subjects at baseline (n = 3671)</td></tr><tr><td rowspan="2">Cases</td><td rowspan="2">Person-y</td><td rowspan="2">Incidence rate<sup>a</sup></td><td colspan="3">Model 1</td><td colspan="3">Model 2</td></tr><tr><td>HR</td><td>95 % CI</td><td>P value</td><td>HR</td><td>95 % CI</td><td>P value</td></tr><tr><td colspan="10">Dominant model</td></tr><tr><td> CC</td><td>130</td><td>6088.5</td><td>21.4</td><td>1.00</td><td>(Reference)</td><td></td><td>1.00</td><td>(Reference)</td><td></td></tr><tr><td> CG + GG</td><td>156</td><td>10727.7</td><td>14.5</td><td>0.68</td><td>(0.54&#8211;0.86)</td><td>0.001</td><td>0.69</td><td>(0.54&#8211;0.87)</td><td>0.002</td></tr></table>
7b8a1850a52a03545f578b0f76f9367aee4473656ac796b5c58f44213bb3aa08.png
simple
<table><tr><td>Variables</td><td>AA (n = 17)</td><td>SS (n = 55)</td></tr><tr><td>TNF-&#945; (pg/mL)</td><td>0(0); 0 7.2</td><td>0.63 (3.90); 0, 15.25*</td></tr><tr><td>IL-1&#946; (pg/mL)</td><td>0 (0.05); 0, 3.3</td><td>0 (0.91); 0, 6.33</td></tr><tr><td>ICAM-1 (ng/mL)</td><td>150.05 (89.91); 0, 249.01</td><td>93.81 (209.28); 0, 445.01</td></tr><tr><td>IL-10 (ng/mL)</td><td>6.36 (3.06); 0, 11.09</td><td>9.12 (12.76); 0, 33.56</td></tr></table>
2398a0044b05d3737048d1b7f0391672544d7d27022b64d99d3d20e125683b43.png
simple
<table><tr><td></td><td>Holistic Affect</td><td>Worry</td><td>Afraid</td><td>Helpless</td><td>Interested</td><td>Angry</td><td>Sad</td><td>Hopeful</td><td>Depressed</td><td>Guilty</td></tr><tr><td>Worry</td><td>0.65**</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Afraid</td><td>0.43**</td><td>0.67**</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Helpless</td><td>0.37**</td><td>0.50**</td><td>0.64**</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Interested</td><td>0.32**</td><td>0.50**</td><td>0.57**</td><td>0.54**</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Angry</td><td>0.24**</td><td>0.41**</td><td>0.57**</td><td>0.48**</td><td>0.53**</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Sad</td><td>0.44**</td><td>0.59**</td><td>0.70**</td><td>0.58**</td><td>0.57**</td><td>0.68**</td><td></td><td></td><td></td><td></td></tr><tr><td>Hopeful</td><td>0.24**</td><td>0.35**</td><td>0.36**</td><td>0.43**</td><td>0.64**</td><td>0.32**</td><td>0.38**</td><td></td><td></td><td></td></tr><tr><td>Depressed</td><td>0.37**</td><td>0.55**</td><td>0.68**</td><td>0.57**</td><td>0.47**</td><td>0.57**</td><td>0.66**</td><td>0.27**</td><td></td><td></td></tr><tr><td>Guilty</td><td>0.34**</td><td>0.54**</td><td>0.65**</td><td>0.51**</td><td>0.43**</td><td>0.41**</td><td>0.56**</td><td>0.35**</td><td>0.59**</td><td></td></tr><tr><td>Disgusted</td><td>0.21**</td><td>0.40**</td><td>0.54**</td><td>0.52**</td><td>0.52**</td><td>0.78**</td><td>0.64**</td><td>0.26**</td><td>0.57**</td><td>0.40**</td></tr></table>
05fdea4cf0ee1ef8e17804864ad12a819534f73489d01038173aed9f04212afe.png
complex
<table><tr><td></td><td></td><td>&#967;<sup>2</sup></td><td><i>P</i> value</td></tr><tr><td rowspan="3">N0</td><td>N1</td><td>5.701</td><td>0.017</td></tr><tr><td>N2</td><td>6.164</td><td>0.013</td></tr><tr><td>N3</td><td>0.316</td><td>0.574</td></tr><tr><td rowspan="2">N1</td><td>N2</td><td>0.379</td><td>0.538</td></tr><tr><td>N3</td><td>0.613</td><td>0.434</td></tr><tr><td>N2</td><td>N3</td><td>1.306</td><td>0.253</td></tr></table>
2627f67ba7916ac679972d8f2bc7b67b5e289edd73eb87ce219bd9193d5a0120.png
simple
<table><tr><td>Case</td><td>Treatment period (course)</td><td>Reason for cessation of therapy</td></tr><tr><td>1</td><td>4</td><td>Originally scheduled</td></tr><tr><td>2</td><td>8</td><td></td></tr><tr><td>3</td><td>8</td><td></td></tr><tr><td>4</td><td>8</td><td></td></tr><tr><td>5</td><td>4</td><td>Changing the treatment</td></tr><tr><td>6</td><td>2</td><td>Severe watering eyes and fatigue</td></tr><tr><td>7</td><td>8</td><td></td></tr><tr><td>8</td><td>2</td><td>Changing the hospital</td></tr><tr><td>9</td><td>8</td><td></td></tr><tr><td>10</td><td>7</td><td>Repeated extension of drug holidays</td></tr><tr><td>11</td><td>6</td><td>Repeated extension of drug holidays</td></tr></table>
d2da39f256b39e5984485a2a1fe998215df83138ee2c8b9c9349a10e976aa473.png
complex
<table><tr><td>Variable</td><td>OR</td><td>SE</td><td>95% CI</td><td><i>p </i>value</td></tr><tr><td colspan="5">Model 1. Knowledge about the modes of transmission and the main preventative measures of HIV (Sample size=244)</td></tr><tr><td colspan="5">Log likelihood=&#8722;118.4, &#967;<sup>2</sup>=37.67 (6 df), <i>p</i>&lt;0.0001</td></tr><tr><td>Physician as source of information about HIV/AIDS</td><td>4.34</td><td>1.71</td><td>2.01-9.42</td><td>&lt;0.001</td></tr><tr><td>Having had more than one sexual partner and no consistent condom use in the last year</td><td>0.33</td><td>0.13</td><td>0.16-0.7</td><td>0.004</td></tr><tr><td>Educational level</td><td> </td><td></td><td> </td><td> </td></tr><tr><td>Middle school or lower</td><td>0.34</td><td>0.16</td><td>0.14-0.84</td><td>0.019</td></tr><tr><td>Baccalaureate degree/graduate degree*</td><td>1.0</td><td> </td><td> </td><td> </td></tr><tr><td>Employment status</td><td>0.63</td><td>0.2</td><td>0.33-1.19</td><td>0.15</td></tr><tr><td>Need of additional information about HIV/AIDS</td><td>0.63</td><td>0.21</td><td>0.33-1.21</td><td>0.17</td></tr><tr><td>Number of other persons in the household</td><td>0.69</td><td>0.27</td><td>0.32-1.47</td><td>0.34</td></tr><tr><td colspan="5">Model 3. Having received the HIV test (Sample size=244)</td></tr><tr><td colspan="5">Log likelihood=&#8722;114.71, &#967;<sup>2</sup>=20.76 (5 df), <i>p</i>&lt;0.0001</td></tr><tr><td>Having visited a physician or having participated in preventive activities about HIV/AIDS</td><td>2.67</td><td>0.93</td><td>1.35-5.29</td><td>0.005</td></tr><tr><td>Gender</td><td>0.42</td><td>1.66</td><td>0.19-0.91</td><td>0.028</td></tr><tr><td>Knowledge about the modes of transmission and the main preventative measures of HIV</td><td>1.73</td><td>0.62</td><td>0.85-3.52</td><td>0.13</td></tr><tr><td>Educational level</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Middle school or lower</td><td>0.54</td><td>0.23</td><td>0.23-1.26</td><td>0.15</td></tr><tr><td>Baccalaureate degree/graduate degree*</td><td>1.0</td><td> </td><td> </td><td> </td></tr><tr><td>Injecting drugs use in the last year</td><td>1.85</td><td>0.8</td><td>0.79-4.33</td><td>0.16</td></tr><tr><td>Variable</td><td>Coeff</td><td>SE</td><td><i>t</i></td><td><i>p </i>value</td></tr><tr><td colspan="5">Model 2. Fear of contracting HIV/AIDS (Sample size=244)</td></tr><tr><td colspan="5">F(6,237)=6.96, <i>p</i>&lt;0.0001, R<sup>2</sup>=15%, adjusted R<sup>2</sup>=12.8%</td></tr><tr><td>Perception of personal health status</td><td>0.25</td><td>0.08</td><td>2.94</td><td>0.004</td></tr><tr><td>Age</td><td>&#8722;0.04</td><td>0.02</td><td>&#8722;2.48</td><td>0.014</td></tr><tr><td>Marital status</td><td>&#8722;0.84</td><td>0.41</td><td>&#8722;2.07</td><td>0.04</td></tr><tr><td>Need of additional information about HIV/AIDS</td><td>0.5</td><td>0.33</td><td>1.5</td><td>0.13</td></tr><tr><td>Gender</td><td>0.51</td><td>0.34</td><td>1.5</td><td>0.13</td></tr><tr><td>Having received the HIV test</td><td>0.39</td><td>0.39</td><td>1.01</td><td>0.31</td></tr><tr><td>Constant</td><td>5.87</td><td> </td><td> </td><td> </td></tr></table>
79745b7cd77d8087ebe817a5b0f460e2de2e1cad8de05b669e00196e98cec66a.png
complex
<table><tr><td>Variable</td><td>n</td><td>%</td></tr><tr><td colspan="3">Official graduation</td></tr><tr><td>Soldier</td><td>99</td><td>60</td></tr><tr><td>Corporal</td><td>38</td><td>23</td></tr><tr><td>Sargent</td><td>17</td><td>10.3</td></tr><tr><td>Sublieutenant</td><td>2</td><td>1.2</td></tr><tr><td>Lieutenant</td><td>5</td><td>3</td></tr><tr><td>Capitan</td><td>2</td><td>1.2</td></tr><tr><td>Major</td><td>2</td><td>1.2</td></tr><tr><td>Total</td><td>165</td><td>100</td></tr><tr><td colspan="3">Operation</td></tr><tr><td>Predominantly administrative</td><td>28</td><td>17</td></tr><tr><td>Predominantly operational</td><td>137</td><td>83</td></tr><tr><td>Total</td><td>165</td><td>100</td></tr><tr><td colspan="3">Years of service</td></tr><tr><td>1-10</td><td>67</td><td>40.6</td></tr><tr><td>11-20</td><td>34</td><td>20.6</td></tr><tr><td>21-30</td><td>62</td><td>37.6</td></tr><tr><td>Above 31</td><td>2</td><td>1.2</td></tr><tr><td>Total</td><td>165</td><td>100</td></tr><tr><td colspan="3">Leisure physical activity level</td></tr><tr><td>Low</td><td>86</td><td>52.1</td></tr><tr><td>Moderate</td><td>37</td><td>22.4</td></tr><tr><td>High</td><td>24</td><td>14.52</td></tr><tr><td>Very high</td><td>18</td><td>10.9</td></tr><tr><td>Total</td><td>165</td><td>100</td></tr><tr><td colspan="3">Coronary risk rating</td></tr><tr><td>Risk much lower than average</td><td>10</td><td>6.1</td></tr><tr><td>Risk lower than average</td><td>58</td><td>35.2</td></tr><tr><td>Medium risk</td><td>70</td><td>42.4</td></tr><tr><td>Moderate risk</td><td>25</td><td>15.2</td></tr><tr><td>High risk</td><td>2</td><td>1.2</td></tr><tr><td>Total</td><td>165</td><td>100</td></tr></table>
902b15eddce6d27087718d91ca907cea5e141386f533839596226963fc481733.png
simple
<table><tr><td> </td><td> </td></tr><tr><td>Age (years, mean &#177; SD (median and range))</td><td>67.8 &#177; 13.5 (68, 35-94)</td></tr><tr><td>Gender (male/female)</td><td>35/26</td></tr><tr><td>Eastern Cooperative Oncology Group Performance Status (0/1/2/3)</td><td>33/13/12/3</td></tr><tr><td>Location (colon/rectum)</td><td>32/29</td></tr><tr><td>Primary tumor-related obstruction (yes/no)</td><td>36/25</td></tr><tr><td>Metastasis (n)</td><td> </td></tr><tr><td> Liver only</td><td>20</td></tr><tr><td> Liver and lung</td><td>10</td></tr><tr><td> Liver and peritoneum</td><td>5</td></tr><tr><td> Extended lymph node only</td><td>4</td></tr><tr><td> Peritoneum only</td><td>4</td></tr><tr><td> Lung only</td><td>1</td></tr><tr><td> Bone only</td><td>1</td></tr><tr><td> Lung and bone</td><td>1</td></tr><tr><td>Treatment (n)</td><td> </td></tr><tr><td> Chemotherapy only</td><td>16</td></tr><tr><td> Surgical intervention + chemotherapy</td><td>25</td></tr><tr><td> Surgical intervention only</td><td>13</td></tr><tr><td> Best supportive care</td><td>7</td></tr></table>
177e462d222b8d5b6747c4810a91f5a7538e629f9a80fbb3a1fce84f3396cd21.png
simple
<table><tr><td>Test</td><td><i>k</i>-mer size</td><td>Promoter Set</td><td>Error (Ave &#177; S.D.)</td></tr><tr><td>(<i>g</i>, <i>k</i>)-table</td><td>6</td><td>small</td><td>3.53e-5 &#177; 1.87e-4</td></tr><tr><td></td><td></td><td>large</td><td>2.65e-5 &#177; 1.04e-4</td></tr><tr><td></td><td>8</td><td>small</td><td>1.84e-5 &#177; 6.57e-5</td></tr><tr><td></td><td></td><td>large</td><td>1.16e-5 &#177; 4.35e-5</td></tr><tr><td>ESAsearch</td><td></td><td>small</td><td>1.23e-4 &#177; 5.96e-4</td></tr><tr><td></td><td></td><td>large</td><td>1.61e-4 &#177; 7.68e-4</td></tr></table>
0b944641cdeab2f202fa3441ac9295aa45084723a1514ded3f2c58ebce81ec8f.png
simple
<table><tr><td>CRB-65 class (risk class)</td><td>2005, n deaths (% of risk class)</td><td>2006, n deaths (% of risk class)</td><td>Total, n deaths (% of risk class)</td></tr><tr><td>RC 1 (CRB-65 = 0)</td><td>532 (1.76)</td><td>1009 (2.97)</td><td>1541 (2.40)</td></tr><tr><td>RC 2 (CRB-65 = 1 or 2)</td><td>15 439 (12.09)</td><td>21 871 (14.56)</td><td>37 310 (13.43)</td></tr><tr><td>RC 3 (CRB-65 = 3 or 4 or requirement for mechanical ventilation at admission)</td><td>9651 (33.56)</td><td>6252 (35.76)</td><td>15 903 (34.39)</td></tr><tr><td>Total deaths</td><td>25 622 (13.72)</td><td>29 132 (14.44)</td><td>54 757 (14.10)</td></tr></table>
75293a619d5258e07541f5e91142de91e77dee0f5f930909ab23487b6f8ac78f.png
simple
<table><tr><td>Characters</td><td><i>V. alces</i><sup>a</sup></td><td><i>V. alces</i><sup>b</sup></td><td><i>V. capreoli</i><sup>c</sup></td><td><i>V.</i>cf.<i>capreoli</i><sup>a</sup></td></tr><tr><td>Total length</td><td>16.3&#8211;21.5 (18.3 &#177; 2.3)</td><td>11.1&#8211;11.5</td><td>9.41&#8211;15</td><td>17.93<sup>*</sup></td></tr><tr><td>Maximum width</td><td>73&#8211;102 (86.0 &#177; 9.9)</td><td>75&#8211;95</td><td>38&#8211;95</td><td>48.9&#8211;52.2 (50.5 &#177; 2.31)</td></tr><tr><td>Esophagus<sup>&#167;</sup></td><td>270&#8211;310 (289 &#177; 14.71)</td><td>&#8211;</td><td>122&#8211;290</td><td>196&#8211;242.9 (225.0 &#177; 20.21)</td></tr><tr><td>Esophagus base width</td><td>30&#8211;42 (36.7 &#177; 4.32)</td><td>&#8211;</td><td>&#8211;</td><td>21.9&#8211;27.7 (23.8 &#177; 2.60)</td></tr><tr><td>Body width at esophagus base</td><td>57&#8211;67 (61.1 &#177; 4.56)</td><td>&#8211;</td><td>&#8211;</td><td>31&#8211;40.8 (35.3 &#177; 5.06)</td></tr><tr><td>Nerve-ring<sup>&#167;</sup></td><td>86&#8211;97 (91.6 &#177; 4.33)</td><td>&#8211;</td><td>72&#8211;90</td><td>55.4&#8211;65.2 (60.7 &#177; 4.49)</td></tr><tr><td>Cervical papillae<sup>&#167;</sup></td><td>150&#8211;180 (163.3 &#177; 15.28)</td><td>&#8211;</td><td>&#8211;</td><td>185.82<sup>*</sup></td></tr><tr><td>Excretory pore<sup>&#167;</sup></td><td>159&#8211;220 (190.4 &#177; 29.11)</td><td>&#8211;</td><td>86&#8211;186</td><td>171.5&#8211;190.8 (183.4 &#177; 10.37)</td></tr><tr><td>Tail</td><td>34.2&#8211;50.5 (44.5 &#177; 4.65)</td><td>&#8211;</td><td>34&#8211;78</td><td>31&#8211;40.8 (37.2 &#177; 3.47)</td></tr><tr><td>Vulva-anus</td><td>70.1&#8211;104 (87.3 &#177; 10.1)</td><td>&#8211;</td><td>&#8211;</td><td>57.1&#8211;73.4 (64.3 &#177; 6.62)</td></tr><tr><td>Vulva-tail</td><td>107.6&#8211;146 (131.9 &#177; 12.77)</td><td>122</td><td>90&#8211;144</td><td>91&#8211;114.1 (101.6 &#177; 8.42)</td></tr><tr><td>Width at vulva</td><td>45.6&#8211;69 (56 &#177; 7.31)</td><td>&#8211;</td><td>&#8211;</td><td>32.2&#8211;35.9 (33.4 &#177; 1.42)</td></tr><tr><td>Vagina</td><td>702.2&#8211;961.42 (846.41 &#177; 94.94)</td><td>&#8211;</td><td>&#8211;</td><td>467<sup>*</sup></td></tr><tr><td>Vagina Vera</td><td>63.3&#8211;71.7 (66.8 &#177; 2.70)</td><td>&#8211;</td><td>&#8211;</td><td>73.4&#8211;91.3 (77.4 &#177; 6.90)</td></tr><tr><td>Vagina Uterina</td><td>637&#8211;889.7 (779.2 &#177; 93.82)</td><td>&#8211;</td><td>&#8211;</td><td>391.2<sup>*</sup></td></tr><tr><td>Sphincter</td><td>21.2&#8211;35.9 (31.8 &#177; 3.96)</td><td>&#8211;</td><td>&#8211;</td><td>24.45<sup>*</sup></td></tr><tr><td>Eggs Length<sup>&#8224;</sup></td><td>55.2&#8211;66.5 (61.9 &#177; 3.51)</td><td>78</td><td>56&#8211;78</td><td>NA</td></tr><tr><td>Eggs Width<sup>&#8224;</sup></td><td>46.2&#8211;63.0 (55.6 &#177; 6.14)</td><td>&#8211;</td><td>37&#8211;45</td><td>NA</td></tr></table>
38647b2e1fa6cc92bb36b7d585059da21e0da81571be3b5e655a6b0e6c61c4c6.png
complex
<table><tr><td></td><td></td><td colspan="3">CONV (N = 2575)</td><td colspan="3">CAM (N = 6595)</td></tr><tr><td></td><td></td><td>#</td><td>%</td><td>95% CI</td><td>#</td><td>%</td><td>95% CI</td></tr><tr><td>Physicians</td><td><i>N</i></td><td>78</td><td>30</td><td></td><td>184</td><td>70</td><td></td></tr><tr><td>Patients</td><td><i>Children (N = 1291)</i></td><td>118</td><td>9</td><td></td><td>1173</td><td>91</td><td></td></tr><tr><td></td><td><i>Adults* (N = 7879)</i></td><td>2457</td><td>31</td><td></td><td>5422</td><td>69</td><td></td></tr><tr><td></td><td><i>All</i></td><td>2575</td><td>28</td><td></td><td>6595</td><td>72</td><td></td></tr><tr><td>Proportion of female, patients</td><td><i>Children**</i></td><td>72</td><td>61</td><td>52&#8211;70</td><td>537</td><td>46</td><td>43&#8211;48</td></tr><tr><td></td><td><i>Adults</i>**</td><td>1405</td><td>57</td><td>54&#8211;60</td><td>3866</td><td>71</td><td>70&#8211;73</td></tr><tr><td></td><td><i>All</i>*</td><td>1477</td><td>57</td><td>54&#8211;61</td><td>4403</td><td>67</td><td>65&#8211;68</td></tr><tr><td>Mean age, patients</td><td><i>Children</i></td><td colspan="3">11 years</td><td colspan="3">7 years</td></tr><tr><td></td><td><i>Adults</i></td><td colspan="3">51 years</td><td colspan="3">49 years</td></tr><tr><td></td><td><i>All</i></td><td colspan="3">49 years</td><td colspan="3">41 years</td></tr></table>
66409e0ff18723cbb699af71dccd362c643421266a8e21a7f8cd3b9365f84e18.png
simple
<table><tr><td></td><td>ISG (95% CI)</td><td>ICBD (95% CI)</td></tr><tr><td>Sensitivity</td><td>77.9% (71.3 to 83.6)</td><td>97.9% (94.7 to 99.4)</td></tr><tr><td>Specificity</td><td>69.1% (58.0 to 78.7)</td><td>19.1% (11.3 to 29.1)</td></tr><tr><td>Positive Likelihood ratio</td><td>2.52 (1.85 to 3.53)</td><td>1.21 (1.10 to 1.28)</td></tr><tr><td>Negative Likelihood ratio</td><td>0.32 (0.24 to 0.43)</td><td>0.11 (0.03 to 0.34)</td></tr><tr><td>Disease prevalence</td><td>69.3% (63.5 to 74.8)</td><td>69.3% (63.5 to 74.8)</td></tr><tr><td>Positive Predictive Value</td><td>85.1% (78.9 to 90.0)</td><td>73.2 (67.3 to 78.6)</td></tr><tr><td>Negative Predictive Value</td><td>58.0 (47.7 to 67.8)</td><td>80.0 (56.3 to 94.3)</td></tr></table>
f1f06f2004dd4f907fa5bc2c7ed400d98264fb1bd8eb64bfcc365d7419333bfa.png
simple
<table><tr><td>Position</td><td>Orientation</td><td>Distance/A&#778;</td><td><i>E</i><sub><i>a</i></sub> (NH<sub>3</sub>)/meV</td><td><i>&#8710;Q</i></td></tr><tr><td>B</td><td>U</td><td>3.40</td><td>31.44</td><td>0.02 e</td></tr><tr><td>C</td><td>U</td><td>3.49</td><td>45.53</td><td>0.02 e</td></tr><tr><td>T</td><td>U</td><td>3.66</td><td>38.04</td><td>0.02 e</td></tr><tr><td>B</td><td>D</td><td>3.46</td><td>39.45</td><td>&#8722;0.01 e</td></tr><tr><td>C</td><td>D</td><td>3.45</td><td>48.87</td><td>&#8722;0.01 e</td></tr><tr><td>T</td><td>D</td><td>3.45</td><td>39.42</td><td>&#8722;0.01 e</td></tr></table>
e595e161ff54d64344c2bc937bcf0f18250c6023066d24694ffcedd90f5a964e.png
complex
<table><tr><td>Characteristics</td><td>Patients (Percentages)</td></tr><tr><td colspan="2">Gender:</td></tr><tr><td> Male</td><td>49 (57)</td></tr><tr><td> Female</td><td>37 (43)</td></tr><tr><td>Median Age:</td><td>63</td></tr><tr><td colspan="2">Surgery:</td></tr><tr><td> Biopsy</td><td>7 (8)</td></tr><tr><td> STR</td><td>32 (37)</td></tr><tr><td> GTR</td><td>47 (55)</td></tr><tr><td colspan="2">Adjuvant treatment:</td></tr><tr><td> Long course adjuvant RT/TMZ</td><td>65 (75)</td></tr><tr><td> Hypofractionated RT/TMZ</td><td>4 (5)</td></tr><tr><td> Hypofractionated RT</td><td>17 (20)</td></tr><tr><td> TMZ alone</td><td>0 (0)</td></tr><tr><td colspan="2">Radiotherapy dose:</td></tr><tr><td> 60Gy</td><td>65 (76)</td></tr><tr><td> 40Gy</td><td>21 (24)</td></tr><tr><td colspan="2">Re-resection rates:</td></tr><tr><td> No further craniotomy</td><td>70 (81)</td></tr><tr><td> Re-resection</td><td>16 (19)</td></tr></table>
b8bc940885dfaa80b58438a274e34e84ade1843d1e7e0e918e3585e8bee925f1.png
simple
<table><tr><td>Attribute</td><td>LMG 727</td><td>%</td><td>LMG 728</td><td>%</td><td>LMG 730</td><td>%</td></tr><tr><td>Genome size (bp)</td><td>4,754,971</td><td>100.00</td><td>4,610,480</td><td>100.00</td><td>4,399,523</td><td>100.00</td></tr><tr><td>DNA coding (bp)</td><td>4,132,338</td><td>86.90</td><td>3,961,227</td><td>85.91</td><td>3,805,731</td><td>86.50</td></tr><tr><td>DNA G+C (bp)</td><td>3,250,022</td><td>68.35</td><td>3,149,419</td><td>68.31</td><td>3,007,954</td><td>68.37</td></tr><tr><td>DNA scaffolds</td><td>58</td><td>100.00</td><td>129</td><td>100.00</td><td>84</td><td>100.00</td></tr><tr><td>Total genes</td><td>3,933</td><td>100.00</td><td>3,906</td><td>100.00</td><td>3,803</td><td>100.00</td></tr><tr><td>Protein coding genes</td><td>3,878</td><td>98.6</td><td>3,851</td><td>98.6</td><td>3,749</td><td>98.6</td></tr><tr><td>RNA genes</td><td>55</td><td>1.40</td><td>55</td><td>1.40</td><td>54</td><td>1.40</td></tr><tr><td>Pseudo genes</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Genes in internal clusters</td><td>978</td><td>24.86</td><td>924</td><td>23.65</td><td>876</td><td>23.03</td></tr><tr><td>Genes with function prediction</td><td>2,781</td><td>70.7</td><td>2,759</td><td>70.63</td><td>2,697</td><td>70.91</td></tr><tr><td>Genes assigned to COGs</td><td>2,987</td><td>75.94</td><td>2,935</td><td>75.14</td><td>2,928</td><td>76.99</td></tr><tr><td>Genes with Pfam domains</td><td>3,045</td><td>77.42</td><td>2,984</td><td>76.39</td><td>2,968</td><td>78.04</td></tr><tr><td>Genes with signal peptides</td><td>585</td><td>14.87</td><td>586</td><td>15</td><td>553</td><td>14.54</td></tr><tr><td>Genes with transmembrane helices</td><td>954</td><td>24.25</td><td>935</td><td>23.93</td><td>918</td><td>24.13</td></tr><tr><td>CRISPR repeats</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr></table>
fd1de28386493670a6192672bcb2dd67df0403de3e1425e3bde6c9efdb9218f2.png
simple
<table><tr><td>Parameter</td><td>Mean &#177; SD</td><td>Range</td></tr><tr><td>Urinary sTNF-R55 (ng/&#956;mol creatinine)</td><td>29.2 &#177; 20.1</td><td>1.94&#8211;117</td></tr><tr><td>Urinary sTNF-R55 (pg/ml)</td><td>277 &#177; 183</td><td>52.0&#8211;861</td></tr><tr><td>Urinary sTNF-R55 (ng/h)</td><td>16.7 &#177; 11.5</td><td>0.94&#8211;81.1</td></tr><tr><td>Urinary protein (mg/&#956;mol creatinine)</td><td>3.20 &#177; 2.25</td><td>0.08&#8211;14.5</td></tr><tr><td>Urinary protein (mg/dl)</td><td>3.48 &#177; 2.58</td><td>0.10&#8211;10.0</td></tr><tr><td>Urinary protein (mg/h)</td><td>1.76 &#177; 1.09</td><td>0.07&#8211;6.38</td></tr><tr><td>Oral ulceration (%)</td><td>0.59 &#177; 2.79</td><td>0.00&#8211;19.9</td></tr><tr><td>Facial rash (%)</td><td>2.67 &#177; 5.60</td><td>0.00&#8211;22.0</td></tr><tr><td>Body temperature (&#176;C)</td><td>36.7 &#177; 0.25</td><td>36.1&#8211;37.4</td></tr><tr><td>Weakness (%)</td><td>7.77 &#177; 5.86</td><td>0.00&#8211;38.0</td></tr><tr><td>Fatigue (%)</td><td>35.2 &#177; 17.2</td><td>6.00&#8211;77.0</td></tr><tr><td>Joint pain (%)</td><td>20.2 &#177; 11.5</td><td>5.00&#8211;54.0</td></tr></table>
384925e21f99400a800142afb016b7936180c40e76760eb134fb5d795e7d85a2.png
simple
<table><tr><td>Medium Cell\Threshold</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td></tr><tr><td>1</td><td>641</td><td>557</td><td>481</td><td>418</td><td>359</td><td>295</td><td>228</td><td>182</td><td>147</td><td>118</td></tr><tr><td>2</td><td>787</td><td>710</td><td>641</td><td>583</td><td>545</td><td>502</td><td>458</td><td>424</td><td>399</td><td>354</td></tr><tr><td>3</td><td>568</td><td>517</td><td>456</td><td>419</td><td>397</td><td>361</td><td>330</td><td>308</td><td>286</td><td>263</td></tr><tr><td>4</td><td>433</td><td>370</td><td>326</td><td>281</td><td>242</td><td>211</td><td>175</td><td>138</td><td>117</td><td>98</td></tr><tr><td>5</td><td>469</td><td>428</td><td>376</td><td>336</td><td>316</td><td>286</td><td>272</td><td>251</td><td>236</td><td>214</td></tr><tr><td>6</td><td>649</td><td>510</td><td>466</td><td>433</td><td>388</td><td>369</td><td>338</td><td>313</td><td>291</td><td>273</td></tr><tr><td>7</td><td>509</td><td>489</td><td>402</td><td>359</td><td>325</td><td>298</td><td>265</td><td>237</td><td>214</td><td>195</td></tr><tr><td>8</td><td>459</td><td>409</td><td>374</td><td>339</td><td>304</td><td>285</td><td>263</td><td>243</td><td>227</td><td>212</td></tr><tr><td>9</td><td>658</td><td>583</td><td>536</td><td>489</td><td>453</td><td>416</td><td>384</td><td>356</td><td>326</td><td>302</td></tr><tr><td>10</td><td>642</td><td>582</td><td>527</td><td>473</td><td>431</td><td>395</td><td>364</td><td>324</td><td>298</td><td>272</td></tr><tr><td>Mean CAV (&#956;m3)</td><td>582</td><td>516</td><td>458</td><td>413</td><td>376</td><td>342</td><td>308</td><td>278</td><td>254</td><td>230</td></tr><tr><td>SD CAV (&#956;m3)</td><td>113</td><td>100</td><td>94</td><td>88</td><td>87</td><td>83</td><td>83</td><td>84</td><td>84</td><td>80</td></tr><tr><td>Number of Cells</td><td>86</td><td>85</td><td>84</td><td>83</td><td>80</td><td>81</td><td>81</td><td>81</td><td>80</td><td>81</td></tr><tr><td>TAV (&#956;m3 * 10E6)</td><td>0.05</td><td>0.04</td><td>0.04</td><td>0.03</td><td>0.03</td><td>0.03</td><td>0.03</td><td>0.02</td><td>0.02</td><td>0.02</td></tr></table>
c907e088d566c98cbe7befb9d01be1b7f4da893c02da769e392e8fe037787ae3.png
simple
<table><tr><td>Gene</td><td>size</td><td>Sense primer</td><td>Antisense primer</td></tr><tr><td><i>Ehvps2</i></td><td>741</td><td>5&#8242;-GCGGATCCATGTCAAGGTTATTC-3&#8242;</td><td>5&#8242;-CCGTCGACTTAAAGATTGGCTATTCT</td></tr><tr><td></td><td></td><td></td><td>TGAAACAATATCATCTTCATCTTC-3&#8242;</td></tr><tr><td><i>Ehvps20</i></td><td>621</td><td>5&#8242;-GCGGATCCATGTTAAATCGATTCA-3&#8242;</td><td>5&#8242;-CCGTCGACTTTAAATTGCAAATTTTTT</td></tr><tr><td></td><td></td><td></td><td>GCTATCTGGTT-3&#8242;</td></tr><tr><td><i>Ehvps20 (1-173)</i></td><td>522</td><td>5&#8242;-CCGGATCCATGTTAAATCGATTCA-3&#8242;</td><td>5&#8242;-CGTCGACTTAAATATCTCCTTCAAACA</td></tr><tr><td></td><td></td><td></td><td>TTGAAT-3&#8242;</td></tr><tr><td><i>Ehvps24</i></td><td>618</td><td>5&#8242;-GCGGATCCATGGGCAACCTTAAT</td><td>5&#8242;-CCGTCGACTTAAAAGGTTTCTATTACA</td></tr><tr><td></td><td></td><td>AGCCAAACAGTAGATAATAG-3&#8242;</td><td>ATATTTTGTTTAGATATTAACATTCACTT-3&#8242;</td></tr><tr><td><i>Ehvps32 (1-165)</i></td><td>495</td><td>5&#8242;-CCCCGGATCCATGTCTTGGTTCA</td><td>5&#8242;-CCCCGTCGACTTATTCTTGTTCATCA</td></tr><tr><td></td><td></td><td>GAAGAAATACTAC-3&#8242;</td><td>AGAACTTGATCTTCTAAT-3&#8242;</td></tr></table>
2b8d27c437a9c65eb0f1eb8a16142d47de98615f7f2c2ccea475d643df1b758b.png
simple
<table><tr><td>Process mode</td><td>Sugar</td><td>Strain</td><td>Time</td><td>CDW</td><td>Sugar consumed</td><td>3HB</td><td>HAc</td><td>mean q<sub>S total</sub></td><td>mean q<sub>3HB</sub></td><td>Y<sub>3HB/HAc</sub></td><td>Y<sub>3HB/CDW</sub></td><td>Y<sub>3HB/Sugar</sub></td></tr><tr><td></td><td></td><td></td><td>(h)</td><td>(g L<sup>&#8722;1</sup>)</td><td>(g L<sup>&#8722;1</sup>)</td><td>(g L<sup>&#8722;1</sup>)</td><td>(g L<sup>&#8722;1</sup>)</td><td>(g g<sup>&#8722;1</sup> h<sup>&#8722;1</sup>)</td><td>(mg g<sup>&#8722;1</sup> h<sup>&#8722;1</sup>)</td><td>(g g<sup>&#8722;1</sup>)</td><td>(g g<sup>&#8722;1</sup>)</td><td>(g g<sup>&#8722;1</sup>)</td></tr><tr><td>Batch</td><td>Glc</td><td>AF1000</td><td>5.5</td><td>4.18</td><td>8.90</td><td>0.51</td><td>0.96</td><td>1.0</td><td>68</td><td>0.54</td><td>0.12</td><td>0.06</td></tr><tr><td>Batch</td><td>Glc + Xyl + Ara</td><td>PPA652ara</td><td>7.3</td><td>4.88</td><td>9.65</td><td>0.31</td><td>0.00</td><td>0.7</td><td>25</td><td>&#8594; &#8734;</td><td>0.06</td><td>0.03</td></tr><tr><td>N-depletion</td><td>Glc + Xyl + Ara</td><td>AF1000</td><td>16.0</td><td>0.27</td><td>2.73</td><td>0.64</td><td>0.48</td><td>0.2</td><td>29</td><td>1.33</td><td>2.37</td><td>0.23</td></tr><tr><td>N-depletion</td><td>Glc + Xyl + Ara</td><td>PPA652ara</td><td>15.0</td><td>0.39</td><td>3.79</td><td>0.54</td><td>0.54</td><td>0.3</td><td>31</td><td>1.00</td><td>1.38</td><td>0.14</td></tr><tr><td>N-fedbatch</td><td>Glc + Xyl + Ara</td><td>AF1000</td><td>11.0</td><td>10.37</td><td>37.05</td><td>1.84</td><td>2.66</td><td>0.6</td><td>45</td><td>0.69</td><td>0.18</td><td>0.05</td></tr><tr><td>N-fedbatch</td><td>Glc + Xyl + Ara</td><td>PPA652ara</td><td>11.0</td><td>11.82</td><td>36.75</td><td>1.87</td><td>0.77</td><td>0.6</td><td>38</td><td>2.43</td><td>0.16</td><td>0.05</td></tr></table>
4f1a202c1ece4381a57f3235d9852528ebccd74bc1fbf1552bf10d32a2e2dc28.png
simple
<table><tr><td>Probe set</td><td>Microarray</td><td>Probe subset</td><td>T0</td><td>T1</td><td>T2</td><td>T4</td><td>T8</td><td>T12</td></tr><tr><td>PrV</td><td>SLA/PrV</td><td>Probes homologous to a single transcript</td><td>0</td><td>3</td><td>7</td><td>18</td><td>26</td><td>30</td></tr><tr><td></td><td></td><td>Total</td><td>0</td><td>3</td><td>13</td><td>34</td><td>52</td><td>58</td></tr><tr><td>Pig</td><td>SLA/PrV</td><td>up-regulated SLA/Immune probes</td><td>0</td><td>0</td><td>0</td><td>1</td><td>4</td><td>3</td></tr><tr><td></td><td></td><td>down regulated SLA/Immune probes</td><td>0</td><td>0</td><td>0</td><td>11</td><td>18</td><td>13</td></tr><tr><td></td><td></td><td>up-regulated random probes</td><td>1</td><td>0</td><td>2</td><td>4</td><td>15</td><td>11</td></tr><tr><td></td><td></td><td>down-regulated random probes</td><td>0</td><td>0</td><td>0</td><td>20</td><td>70</td><td>80</td></tr><tr><td></td><td></td><td>Total</td><td>1</td><td>0</td><td>2</td><td>36</td><td>107</td><td>107</td></tr><tr><td></td><td>Qiagen- NRSP8</td><td>up-regulated probes</td><td>ND*</td><td>27</td><td>134</td><td>1262</td><td>3184</td><td>ND*</td></tr><tr><td></td><td></td><td>down-regulated probes</td><td>ND*</td><td>4</td><td>47</td><td>1494</td><td>3509</td><td>ND*</td></tr><tr><td></td><td></td><td>Total</td><td>ND*</td><td>31</td><td>181</td><td>2756</td><td>6693</td><td>ND*</td></tr></table>
c60ec73b3ab2849b85dce9355ec1c8d3d21771a97f2ab650f01ed07f32c798c3.png
simple
<table><tr><td></td><td>Morphed</td><td>Non-morphed</td></tr><tr><td>Same identity</td><td>Not associated during training</td><td>Associated during training</td></tr><tr><td>Different identity</td><td>Associated during training</td><td>Not associated during training</td></tr></table>
093db63011d9ab1d516edd11840b26471c3a02eb25f7a9d5a2624069120c3647.png
complex
<table><tr><td colspan="4">MOTHERS</td><td colspan="4">INFANTS</td></tr><tr><td></td><td>N</td><td>&#952;<sub>w</sub></td><td>&#952;<sub>c</sub></td><td></td><td></td><td>&#952;<sub>w</sub></td><td>&#952;<sub>c</sub></td></tr><tr><td>Mother B</td><td>12</td><td>0.015</td><td>0.038</td><td>Infant B</td><td>12</td><td>0.014</td><td>0.033</td></tr><tr><td>Mother C</td><td>12</td><td>0.025</td><td>0.058</td><td>Infant C</td><td>13</td><td>0.021</td><td>0.060</td></tr><tr><td>Mother D</td><td>11</td><td>0.017</td><td>0.042</td><td>Infant D</td><td>10</td><td>0.019</td><td>0.040</td></tr><tr><td>Mother F</td><td>14</td><td>0.012</td><td>0.029</td><td>Infant F</td><td>12</td><td>0.018</td><td>0.053</td></tr><tr><td>Mother H</td><td>14</td><td>0.020</td><td>0.020</td><td>Infant H1</td><td>11</td><td>0.009</td><td>0.016</td></tr><tr><td></td><td></td><td></td><td></td><td>Infant H2</td><td>11</td><td>0.015</td><td>0.044</td></tr><tr><td>Totals</td><td>63</td><td>0.018</td><td>0.037</td><td></td><td>69</td><td>0.016</td><td>0.041</td></tr></table>
e8da83080cda0b0ddad301730cfc3086582497d1a23b9ccb9a456fb622e1748c.png
simple
<table><tr><td></td><td>Phe/protein goals</td><td>Formula goals</td><td>Healthy food choices</td></tr><tr><td>Precontemplation</td><td>1</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Contemplation</td><td>6</td><td>&#8211;</td><td>5</td></tr><tr><td>Preparation</td><td>5</td><td>5</td><td>5</td></tr><tr><td>Action</td><td>5</td><td>6</td><td>10</td></tr><tr><td>Maintenance</td><td>14</td><td>20</td><td>11</td></tr></table>
e1052c69f1141043e6b769c1cbad36436b81dcefb19adcbd576b7b15d81b8f62.png
simple
<table><tr><td>Variable</td><td><i>n</i></td><td>%</td></tr><tr><td>Gender</td><td> </td><td> </td></tr><tr><td> Female</td><td>1371</td><td>62.1</td></tr><tr><td> Male</td><td>836</td><td>37.9</td></tr><tr><td>Age</td><td> </td><td> </td></tr><tr><td> &#8804;16 years</td><td>1259</td><td>57.3</td></tr><tr><td> &#8805;17 years</td><td>940</td><td>42.7</td></tr><tr><td>Socioeconomic status</td><td> </td><td> </td></tr><tr><td> High (A1, A2, B1, B2)</td><td>517</td><td>23.7</td></tr><tr><td> Intermediate (C1, C2)</td><td>1383</td><td>63.4</td></tr><tr><td> Low (&#8220;D&#8221; and &#8220;E&#8221;)</td><td>280</td><td>12.8</td></tr><tr><td>Violent behavior</td><td> </td><td> </td></tr><tr><td> Yes</td><td>363</td><td>16.5</td></tr><tr><td> No</td><td>1842</td><td>83.5</td></tr><tr><td>Cigarette smoking</td><td> </td><td> </td></tr><tr><td> Yes</td><td>146</td><td>6.6</td></tr><tr><td> No</td><td>2051</td><td>93.4</td></tr><tr><td>Alcohol consumption</td><td> </td><td> </td></tr><tr><td> Yes</td><td>844</td><td>38.5</td></tr><tr><td> No</td><td>1350</td><td>61.5</td></tr><tr><td>Marijuana consumption</td><td> </td><td> </td></tr><tr><td> Yes</td><td>53</td><td>2.4</td></tr><tr><td> No</td><td>2140</td><td>97.6</td></tr><tr><td>Body shape satisfaction</td><td> </td><td> </td></tr><tr><td> Satisfied</td><td>1314</td><td>59.9</td></tr><tr><td> Dissatisfied</td><td>879</td><td>40.1</td></tr><tr><td>Physical activity</td><td> </td><td> </td></tr><tr><td> Low levels</td><td>1945</td><td>89.2</td></tr><tr><td> Active</td><td>236</td><td>10.8</td></tr><tr><td>Suicide ideation</td><td> </td><td> </td></tr><tr><td> Yes</td><td>307</td><td>14.0</td></tr><tr><td> No</td><td>1889</td><td>86.0</td></tr><tr><td>Suicide plan</td><td> </td><td> </td></tr><tr><td> Yes</td><td>208</td><td>9.5</td></tr><tr><td> No</td><td>1992</td><td>90.5</td></tr><tr><td>Suicide attempt</td><td> </td><td> </td></tr><tr><td> Yes</td><td>131</td><td>5.9</td></tr><tr><td> No</td><td>94.1</td><td>94.1</td></tr></table>
183c313555ba2997bf2eeb2d140fd2a37c04d4a100ef080f490327132ca0c813.png
simple
<table><tr><td>Baseline characteristic variables</td><td>Intervention group (<i>n</i> = 70)</td><td>Control group (<i>n</i> = 72)</td><td>Meaningful level (<i>P</i> value)</td></tr><tr><td>Age (mean &#177; SD)</td><td>32.04 &#177; 5.901</td><td>29.77 &#177; 5.21</td><td>0.017</td></tr><tr><td>Number of previous pregnancies (mean &#177; SD)</td><td>3.04 &#177; 1.13</td><td>2.92 &#177; .900</td><td>0.463</td></tr><tr><td>Weeks of pregnancy(mean &#177; SD)</td><td>14.39 &#177; 3.12</td><td>14.39 &#177; 2.69</td><td>0.997</td></tr><tr><td>Systolic blood pressure(mm Hg; mean &#177; SD)</td><td>115.87 &#177; 14.52</td><td>114.51 &#177; 7.27</td><td>0.028</td></tr><tr><td>Diastolic blood pressure(mm Hg; mean &#177; SD)</td><td>74.28 &#177; 4.95</td><td>74.31 &#177; 6.40</td><td>0.975</td></tr><tr><td>Uterine &#8595; cm(mean &#177; SD)</td><td>14.58 &#177; 3.50</td><td>14.28 &#177; 3.26</td><td>0.597</td></tr><tr><td>24 h proteinuria (mg/cc;mean &#177; SD)</td><td>132.22/1844.91 &#177; 61.447</td><td>154.94/1958.53 &#177; 53.376</td><td>0.023</td></tr><tr><td>BMI &lt; 18.5 kg/m<sup>2</sup> (<i>n</i> (%))</td><td>1 (1.4%)</td><td>1 (1.4%)</td><td>0.267</td></tr><tr><td>BMI, 18.5&#8211;24.9 kg/m<sup>2</sup> (<i>n</i> (%))</td><td>23 (32.9%)</td><td>14 (19.4%)</td><td>0.267</td></tr><tr><td>BMI, 25.0&#8211;29.9 kg/m<sup>2</sup> (<i>n</i> (%))</td><td>32 (45.7%)</td><td>35 (49.3%)</td><td>0.267</td></tr><tr><td>BMI &#8805; 30.0 kg/m<sup>2</sup> (<i>n</i> (%))</td><td>13 (18.6%)</td><td>21 (29.6%)</td><td>0.267</td></tr></table>
3a8b3d9348c0cdb3ef91953fdac3afa362ba6bb73d8b3dcfed35aa25c21b0df5.png
simple
<table><tr><td>Mean&#177; SD</td><td>Poor collateral</td><td>Good collateral</td><td>P value</td></tr><tr><td>Number (%)</td><td>(n = 122)</td><td>(n = 80)</td><td> </td></tr><tr><td>Number of diseased vessels</td><td>2.1 &#177; 0.9</td><td>2.6 &#177; 0.6</td><td>&lt;0.001</td></tr><tr><td>Significant CAD, n (%)</td><td> </td><td> </td><td> </td></tr><tr><td>1 vessel disease (%)</td><td>47 (38.5)</td><td>12 (15.0)</td><td> </td></tr><tr><td>2 vessel disease (%)</td><td>41 (33.6)</td><td>21 (26.3)</td><td>&lt;0.001</td></tr><tr><td>3 vessel disease (%)</td><td>34 (27.9)</td><td>47 (58.8)</td><td> </td></tr><tr><td>Diffuse score of CAD</td><td>3.01 &#177; 1.75</td><td>4.03 &#177; 1.83</td><td>&lt;0.001</td></tr><tr><td>1 vessel disease</td><td>1.25 &#177; 0.67</td><td>1.42 &#177; 0.66</td><td> </td></tr><tr><td>2 vessel disease</td><td>2.72 &#177; 0.86</td><td>2.84 &#177; 0.99</td><td> </td></tr><tr><td>3 vessel disease</td><td>4.41 &#177; 1.43</td><td>4.84 &#177; 1.63</td><td> </td></tr></table>
2a54ea2c54fe89dfe5c8616328631b9fcba39903eef0ba5805c8bcf2d1114587.png
complex
<table><tr><td>Gene ID</td><td>Gene</td><td>Regulation</td><td colspan="3">Computational matching of regulatory consensus</td><td colspan="2">Position of DNA fragment used <sup>&#167;</sup></td></tr><tr><td></td><td></td><td></td><td>Position&#167;</td><td>Sequence</td><td>Score</td><td>LacZ</td><td>Footprinting</td></tr><tr><td>YPO1222</td><td><i>ompC</i></td><td>+</td><td>R-191...-169</td><td>AAACAGTGAGTTATAGCACATAT</td><td>12.3</td><td>-379...+130</td><td>-281...-26</td></tr><tr><td>YPO1411</td><td><i>ompF</i></td><td>+</td><td>D-131...-109</td><td>ACTTTGTGACTTAGATCGAATTT</td><td>10.73</td><td>-328...+143</td><td>-237...-4</td></tr><tr><td>YPO2506</td><td><i>ompX</i></td><td>-</td><td>D-156...-134</td><td>AGTATGTGACCTCCATCACCCAA</td><td>11.68</td><td>-374...+123</td><td>-321...+4</td></tr><tr><td>YPO0136</td><td><i>ompR</i></td><td>NO</td><td>-</td><td>-</td><td>0</td><td>-409...+83</td><td>-409...+83</td></tr><tr><td>YPO0175</td><td><i>crp</i></td><td>NO</td><td>R+235...+257</td><td>GAACTCTGAGCCCTGTTAAGTTA</td><td>1.44</td><td>-147...+344</td><td>-147...+344</td></tr></table>
7c259f4f5261acc4ebeb05b9e5ea1da287ff9f9755eeedeac1ef46d207ad06e6.png
complex
<table><tr><td colspan="2">Target radius [px]</td><td>15</td><td>20</td><td>25</td><td>30</td></tr><tr><td>Feedback factor</td><td>0.3</td><td>7.0 (10.0)</td><td>6.1 (8.2)</td><td>13.2 (13.7)</td><td>16.6 (21.0)</td></tr><tr><td></td><td>0.8</td><td>28.2 (21.6)</td><td>34.8 (25.7)</td><td>52.7 (33.2)</td><td>56.8 (35.1)</td></tr><tr><td></td><td>1.3</td><td>48.5 (28.1)</td><td>64.4 (29.2)</td><td>69.5 (28.9)</td><td>82.4 (27.5)</td></tr><tr><td></td><td>1.8</td><td>67.3 (29.7)</td><td>77.1 (25.4)</td><td>90.0 (14.3)</td><td>93.0 (14.4)</td></tr></table>
0be450d44e56d01fbec200e85673c0ab62c7580bb170606e6d913230c11943fa.png
complex
<table><tr><td>Exon</td><td>Name</td><td>Target</td><td>Amplicon size</td><td>Sequence (5&#8217;&#8211;3&#8217;)</td></tr><tr><td rowspan="3">18</td><td>18 FP</td><td>G719A/S/C</td><td>112 bp</td><td><i>CAGGAAACAGCTATGACC</i>TGGAGCCTCTTACACCCAGT</td></tr><tr><td>18 RP</td><td></td><td></td><td>ACCGTGCCGAACGCACCGGA</td></tr><tr><td>18 LNA</td><td></td><td></td><td>GAGCCCAGC</td></tr><tr><td rowspan="3">19</td><td>19 FP</td><td>Deletions</td><td>176 bp</td><td>GTTAAAATTCCCGTCGCTATCA</td></tr><tr><td>19 RP</td><td></td><td></td><td><i>TGTAAAACGACGGCCAGT</i>TGTGGAGATGAGCAGGGTCT</td></tr><tr><td>19 LNA</td><td></td><td></td><td>CAAGGAATTAAGA</td></tr><tr><td rowspan="3">20</td><td>20 FP</td><td>Insertions</td><td>161 bp</td><td>GAAGCCTACGTGATGGCCA</td></tr><tr><td>20 RP</td><td></td><td></td><td><i>CAGGAAACAGCTATGACC</i>AGCAGGTACTGGGAGCCAAT</td></tr><tr><td>20 LNA</td><td></td><td></td><td>CAGCGTGGACA</td></tr><tr><td>-</td><td>M13-tag 1</td><td>For Sanger sequencing</td><td>-</td><td>TGTAAAACGACGGCCAGT</td></tr><tr><td>-</td><td>M13-tag 2</td><td>For Sanger sequencing</td><td>-</td><td>CAGGAAACAGCTATGACC</td></tr></table>
460c0ae1ed7db5af25c699dd503d58395bb872b6115a8333cfdc5bc7f2789bcd.png
simple
<table><tr><td>Covariates</td><td> dfAIC</td><td> dfAICc</td><td> dfBIC</td><td> dfREML</td></tr><tr><td> DI </td><td>14.99 </td><td>14.99</td><td>5.10</td><td>6.39</td></tr><tr><td>Size </td><td>10.98 </td><td>10.63</td><td>1.78</td><td>2.78</td></tr><tr><td>LNI </td><td>2.01 </td><td>1.50 </td><td>1.50</td><td>2.18</td></tr></table>
9ca77c66b286acaf5be4ff709529b81bfedb1407c59290344631f05f1129766f.png
complex
<table><tr><td rowspan="2">Number of helminth infections</td><td colspan="2">All asthma</td><td colspan="2">Non-atopic asthma</td><td colspan="3">Atopic asthma</td></tr><tr><td>n (%)</td><td>*OR (95% CI)</td><td>n (%)</td><td>**Non-atopic/non-asthmatic</td><td>n (%)</td><td>**Non-atopic/non-asthmatic</td><td>**Atopic/non-asthmatic</td></tr><tr><td>0</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(n = 580; 45.6%)</td><td>164 (28.3)</td><td>1</td><td>59 (10.2)</td><td>1</td><td>60 (10.3)</td><td>1</td><td>1</td></tr><tr><td>1</td><td></td><td>1.02</td><td></td><td>1.40</td><td></td><td>1.24</td><td>1.01</td></tr><tr><td>(n = 463; 36.4%)</td><td>133 (28.7)</td><td>(0.78; 1.34)</td><td>60 (13.0)</td><td>(0.92; 2.11)</td><td>51 (11.0)</td><td>(0.81; 1.90)</td><td>(0.69; 1.74)</td></tr><tr><td>2</td><td></td><td>1.20</td><td></td><td>1.33</td><td></td><td>1.23</td><td>1.01</td></tr><tr><td>(n = 162; 12.8%)</td><td>52 (32.1)</td><td>(0.82; 1.75)</td><td>21 (13.0)</td><td>(0.74; 2.38)</td><td>19 (11.7)</td><td>(0.68; 2.23)</td><td>(0.53; 1.92)</td></tr><tr><td>3</td><td></td><td>1.55</td><td></td><td>1.84</td><td></td><td>0.91</td><td>1.02</td></tr><tr><td>(n = 66; 5.2%)</td><td>25 (37.9)</td><td>(0.91; 2.63)</td><td>12 (18.2)</td><td>(0.87; 3.89)</td><td>6 (9.1)</td><td>(0.36; 2.34)</td><td>(0.37; 2.84)</td></tr></table>
8e9c344f4d74a9e7df7c242aba16ec601fb8527fd096878b1f7e6c69ef5fda93.png
complex
<table><tr><td colspan="2"></td><td colspan="6"><i>P</i> value of the Wilcoxon signed-rank test</td></tr><tr><td>DSSs</td><td>PRM (Degree)</td><td>LPDS</td><td>BRDS</td><td>FUDS</td><td>LBDS</td><td>LFDS</td><td>BFDS</td></tr><tr><td>LPDS</td><td colspan="7">4.02 &#177; 1.84</td></tr><tr><td>BRDS</td><td>39.70 &#177; 4.60</td><td colspan="6">&lt;0.001</td></tr><tr><td>FUDS</td><td>0.93 &#177; 1.06</td><td>&lt;0.001</td><td colspan="5">&lt;0.001</td></tr><tr><td>LBDS</td><td>31.44 &#177; 5.10</td><td>&lt;0.001</td><td>&lt;0.001</td><td colspan="4">&lt;0.001</td></tr><tr><td>LFDS</td><td>4.22 &#177; 2.26</td><td>0.823</td><td>&lt;0.001</td><td>&lt;0.001</td><td colspan="3">&lt;0.001</td></tr><tr><td>BFDS</td><td>37.67 &#177; 8.68</td><td>&lt;0.001</td><td>0.723</td><td>&lt;0.001</td><td>0.003</td><td colspan="2">&lt;0.001</td></tr><tr><td>LBFDS</td><td>31.31 &#177; 6.11</td><td>&lt;0.001</td><td>&lt;0.001</td><td>&lt;0.001</td><td>0.852</td><td>&lt;0.001</td><td>0.004</td></tr><tr><td colspan="4"><i>P</i> value of the Friedman test</td><td colspan="4">&lt;0.001</td></tr></table>
3de31d15bd1dde18cc6b0f7b0e5c0d6aed9851a2782728d1d66e28c205fab865.png
simple
<table><tr><td>Key inclusion criteria</td><td>Key exclusion criteria</td></tr><tr><td>- Male or female patients &#8805;18 years old.</td><td>- Patients with a history of acute rejection classified &gt; BANFF II, chronic active antibody-mediated rejection or chronic T-cell-mediated rejection.</td></tr><tr><td>- Recipients of deceased or living kidney transplants.</td><td>- Patients with an EC-MPS dose of &lt;720 mg/d (MMF &lt;1000 mg/d) and MPA-AUC &lt;30 mg<sup>*</sup>h/L.</td></tr><tr><td>- Time after the last renal transplantation at least six months.</td><td>- Patients with symptoms of significant somatic or mental illness. Inability to cooperate or communicate with the investigator, who are unlikely to comply with the study requirements, or who are unable to give informed consent.</td></tr><tr><td>- Stable renal allograft function, defined as S-creatinine &#8804;3.5 mg/dL and &#916; S-creatinine &#8804;30% during the last three months.</td><td>- Females of childbearing potential who are planning to become pregnant, who are pregnant or lactating, and/or who are unwilling to use effective means of contraception, unless</td></tr><tr><td>- Patients who are willing and able to participate in the study and from whom written informed consent has been obtained.</td><td>a. their career, lifestyle, or sexual orientation precludes intercourse with a male partner,orb. their partners have been sterilised by vasectomy or other means</td></tr><tr><td></td><td>- Evidence of drug or alcohol abuse</td></tr><tr><td></td><td>- Patients actively taking part in an interventional trial</td></tr></table>
89dcd8a7c291eaed1ebd18940e49d2ccba31e349267ed76d7c1b7498fff1ae23.png
complex
<table><tr><td>ORF</td><td>Gene Symbol</td><td>EC</td><td>Enzyme</td><td>Evidence</td></tr><tr><td colspan="5">a) Intersection of our predictions with the experimental screen</td></tr><tr><td>STM0123</td><td>murE</td><td>6.3.2.13</td><td>UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase</td><td>**</td></tr><tr><td>STM0128</td><td>murG</td><td>2.4.1.227</td><td>N-acetylglucosaminyl transferase</td><td>*</td></tr><tr><td>STM0129</td><td>murC</td><td>6.3.2.8</td><td>UDP-N-acetylmuramate-L-alanine ligase</td><td>**</td></tr><tr><td>STM0154</td><td>lpdA</td><td>1.8.1.4</td><td>Dihydrolipoamide dehydrogenase</td><td></td></tr><tr><td>STM0218</td><td>pyrH</td><td>2.7.4.22</td><td>Uridylate kinase</td><td>*</td></tr><tr><td>STM0221</td><td>uppS</td><td>2.5.1.31</td><td>Undecaprenyl pyrophosphate synthase</td><td>**</td></tr><tr><td>STM0222</td><td>cdsA</td><td>2.7.7.41</td><td>CDP-diglyceride synthase</td><td></td></tr><tr><td>STM0228</td><td>lpxA</td><td>2.3.1.129</td><td>UDP-N-acetylglucosamine acyltransferase</td><td></td></tr><tr><td>STM0232</td><td>accA</td><td>6.4.1.2</td><td>Acetyl-CoA carboxylase</td><td>**</td></tr><tr><td>STM0489</td><td>hemH</td><td>4.99.1.1</td><td>Ferrochelatase</td><td>*</td></tr><tr><td>STM0535</td><td>lpxH</td><td></td><td>UDP-2,3-diacylglucosamine hydrolase</td><td></td></tr><tr><td>STM0542</td><td>folD</td><td>1.5.1.5, 3.5.4.9</td><td>Bifunctional 5,10-methylene-tetrahydrofolate dehydrogenase</td><td></td></tr><tr><td>STM0988</td><td>kdsB</td><td>2.7.7.38</td><td>CTP:CMP-KDO cytidylyltransferase</td><td>*</td></tr><tr><td>STM1194</td><td>fabD</td><td>2.3.1.39</td><td>Acyl carrier protein S-malonyltransferase</td><td>*</td></tr><tr><td>STM1195</td><td>fabG</td><td>1.1.1.100</td><td>3-ketoacyl-(acyl-carrier-protein) reductase</td><td>**</td></tr><tr><td>STM1200</td><td>tmk</td><td>2.7.4.9</td><td>Thymidylate kinase</td><td></td></tr><tr><td>STM1700</td><td>fabI</td><td>1.3.1.10</td><td>Enoyl-(acyl carrier protein) reductase</td><td></td></tr><tr><td>STM2483</td><td>dapE</td><td>3.5.1.18</td><td>Succinyl-diaminopimelate desuccinylase</td><td></td></tr><tr><td>STM2652</td><td>pssA</td><td>2.7.8.8</td><td>Phosphatidylserine synthase</td><td>*</td></tr><tr><td>STM3090</td><td>metK</td><td>2.5.1.6</td><td></td><td></td></tr><tr><td>STM3415</td><td>rpoA</td><td>2.7.7.6</td><td>DNA-directed RNA polymerase subunit alpha</td><td></td></tr><tr><td>STM3724</td><td>kdtA</td><td></td><td>3-deoxy-D-manno-octulosonic-acid transferase</td><td>*</td></tr><tr><td>STM3730</td><td>dfp</td><td>4.1.1.36</td><td>Pantothenate kinase</td><td>**</td></tr><tr><td>STM3912</td><td>rep</td><td>3.6.1.-</td><td>ATP-dependent DNA helicase Rep</td><td>*</td></tr><tr><td>STM3978</td><td>yigC</td><td></td><td>3-octaprenyl-4-hydroxybenzoate decarboxylase</td><td></td></tr><tr><td>STM4153</td><td>rpoB</td><td>2.7.7.6</td><td>DNA-directed RNA polymerase subunit beta</td><td>*</td></tr><tr><td>STM4154</td><td>rpoC</td><td>2.7.7.6</td><td>DNA-directed RNA polymerase subunit beta'</td><td></td></tr><tr><td colspan="5">b) Predictions for the non-mevalonate pathway</td></tr><tr><td>STM0049</td><td>ispH, lytB</td><td>1.17.1.2</td><td>4-hydroxy-3-methylbut-2-enyl diphosphate reductase</td><td>*</td></tr><tr><td>STM0220</td><td>dxr</td><td>1.1.1.267</td><td>1-deoxy-D-xylulose 5-phosphate reductoisomerase</td><td>*</td></tr><tr><td>STM0422</td><td>dxs</td><td>2.2.1.7</td><td>1-deoxy-D-xylulose-5-phosphate synthase</td><td>**</td></tr><tr><td>STM0423</td><td>ispA</td><td>2.5.1.10</td><td>geranyltranstransferase</td><td>*</td></tr><tr><td>STM1779</td><td>ispE, ipk</td><td>2.7.1.149</td><td>4-diphosphocytidyl-2-C-methyl-D-erythritol kinase</td><td>**</td></tr><tr><td>STM2523</td><td>ispG, gcpE</td><td>1.17.7.1</td><td>4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase</td><td>*</td></tr><tr><td>STM2929</td><td>ispF</td><td>4.6.1.12</td><td>2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase</td><td>*</td></tr><tr><td>STM2930</td><td>ispD</td><td>2.7.7.60</td><td>2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase</td><td>*</td></tr></table>
52eab7279cfd5de28ed8660ef4d427f4ba0c8a0a788d42d4c1742970ea96737c.png
simple
<table><tr><td>Species</td><td>FTa</td><td>FTb</td><td>FTc</td><td>MFT</td><td>TFL1</td><td>BFT</td><td>Total</td></tr><tr><td><i>A. duranensis</i></td><td>3</td><td>4</td><td>1</td><td>2</td><td>2</td><td>1</td><td>13</td></tr><tr><td><i>A. ipaensis</i></td><td>4</td><td>4</td><td>1</td><td>2</td><td>3</td><td>1</td><td>15</td></tr><tr><td><i>C. cajan</i></td><td>2</td><td>2</td><td>0</td><td>1</td><td>3</td><td>1</td><td>9</td></tr><tr><td><i>C. arietinum</i></td><td>3</td><td>1</td><td>1</td><td>1</td><td>5</td><td>1</td><td>12</td></tr><tr><td><i>G. max</i></td><td>4</td><td>4</td><td>2</td><td>1</td><td>5</td><td>2</td><td>18</td></tr><tr><td><i>L. japonicus</i></td><td>1</td><td>2</td><td>0</td><td>1</td><td>2</td><td>0</td><td>6</td></tr><tr><td><i>L. angustifolius</i></td><td>2</td><td>0</td><td>2</td><td>3</td><td>4</td><td>1</td><td>12</td></tr><tr><td><i>M. truncatula</i></td><td>3</td><td>2</td><td>1</td><td>1</td><td>3</td><td>1</td><td>11</td></tr><tr><td><i>P. vulgaris</i></td><td>2</td><td>2</td><td>1</td><td>1</td><td>3</td><td>1</td><td>10</td></tr><tr><td><i>V. radiata</i></td><td>2</td><td>4</td><td>1</td><td>1</td><td>3</td><td>1</td><td>12</td></tr><tr><td>Total</td><td>26</td><td>25</td><td>10</td><td>14</td><td>33</td><td>10</td><td>118</td></tr></table>
5a8928ee50801f6c59bc95ae5231b1974f4a4a9c0a38cde7f0d2295501fcc79b.png
complex
<table><tr><td> </td><td rowspan="3"><i>n*</i></td><td>Discomfort</td><td>Lack of motivation</td><td>Lack of time</td><td>Lack of social support</td><td>Poor environment</td></tr><tr><td> </td><td>Median (25%&#8211;75%)<sup>&#8224;</sup></td><td>Median (25%&#8211;75%)<sup>&#8224;</sup></td><td>Median (25%&#8211;75%)<sup>&#8224;</sup></td><td>Median (25%&#8211;75%)<sup>&#8224;</sup></td><td>Median (25%&#8211;75%)<sup>&#8224;</sup></td></tr><tr><td>Overall</td><td> </td><td>1.8 (1.3&#8211;2.4)</td><td>2.9 (2.1&#8211;3.7)</td><td>3.0 (2.3&#8211;3.8)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.2 (1.4&#8211;3.0)</td></tr><tr><td colspan="7">Sex</td></tr><tr><td>&#8203; Male</td><td>403</td><td>2.0 (1.4&#8211;2.5)</td><td>2.9 (2.1&#8211;3.7)</td><td>3.0 (2.3&#8211;3.8)</td><td>1.8 (1.1&#8211;2.4)</td><td>2.3 (1.5&#8211;3.0)</td></tr><tr><td>&#8203; Female</td><td>462</td><td>1.7 (1.3&#8211;2.4)</td><td>3.0 (2.2&#8211;3.6)</td><td>3.1 (2.3&#8211;3.8)</td><td>1.6 (1.1&#8211;2.2)</td><td>2.2 (1.4&#8211;3.0)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>0.028</td><td>0.944</td><td>0.952</td><td>0.102</td><td>0.282</td></tr><tr><td colspan="7">Age, years</td></tr><tr><td>&#8203; 20&#8211;39</td><td>275</td><td>1.8 (1.3&#8211;2.5)</td><td>3.1 (2.3&#8211;3.9)</td><td>3.3 (2.6&#8211;3.9)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.3 (1.4&#8211;3.1)</td></tr><tr><td>&#8203; 40&#8211;59</td><td>373</td><td>1.9 (1.4&#8211;2.5)</td><td>3.0 (2.2&#8211;3.7)</td><td>3.2 (2.5&#8211;3.9)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.1 (1.4&#8211;2.9)</td></tr><tr><td>&#8203; 60&#8211;69</td><td>217</td><td>1.8 (1.3&#8211;2.4)</td><td>2.6 (1.8&#8211;3.3)</td><td>2.4 (1.7&#8211;3.2)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.4 (1.5&#8211;3.0)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#167;</sup></td><td> </td><td>0.320</td><td>&lt;0.001</td><td>&lt;0.001</td><td>0.706</td><td>0.155</td></tr><tr><td colspan="7">Location of residence</td></tr><tr><td>&#8203; Tsukuba</td><td>207</td><td>1.8 (1.3&#8211;2.5)</td><td>2.9 (2.1&#8211;3.7)</td><td>3.0 (2.3&#8211;3.9)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.2 (1.4&#8211;3.0)</td></tr><tr><td>&#8203; Koganei</td><td>248</td><td>1.8 (1.4&#8211;2.4)</td><td>3.0 (2.3&#8211;3.8)</td><td>3.1 (2.5&#8211;3.7)</td><td>1.6 (1.1&#8211;2.2)</td><td>2.3 (1.6&#8211;3.0)</td></tr><tr><td>&#8203; Shizuoka</td><td>222</td><td>1.9 (1.3&#8211;2.5)</td><td>3.0 (2.2&#8211;3.6)</td><td>3.0 (2.2&#8211;3.9)</td><td>1.7 (1.1&#8211;2.4)</td><td>2.3 (1.5&#8211;3.0)</td></tr><tr><td>&#8203; Kagoshima</td><td>188</td><td>1.8 (1.3&#8211;2.3)</td><td>2.8 (2.0&#8211;3.5)</td><td>2.9 (2.1&#8211;3.6)</td><td>1.7 (1.1&#8211;2.3)</td><td>2.1 (1.3&#8211;2.9)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#167;</sup></td><td> </td><td>0.501</td><td>0.203</td><td>0.149</td><td>0.603</td><td>0.215</td></tr><tr><td colspan="7">Education, years</td></tr><tr><td>&#8203; &lt;13</td><td>332</td><td>1.8 (1.4&#8211;2.5)</td><td>2.7 (1.9&#8211;3.4)</td><td>2.8 (2.1&#8211;3.6)</td><td>1.7 (1.1&#8211;2.3)</td><td>2.2 (1.4&#8211;3.0)</td></tr><tr><td>&#8203; &#8805;13</td><td>529</td><td>1.8 (1.3&#8211;2.4)</td><td>3.1 (2.3&#8211;3.8)</td><td>3.2 (2.4&#8211;3.8)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.2 (1.5&#8211;3.0)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>0.751</td><td>&lt;0.001</td><td>0.001</td><td>0.193</td><td>0.979</td></tr><tr><td colspan="7">Marital status</td></tr><tr><td>&#8203; Married</td><td>650</td><td>1.9 (1.3&#8211;2.4)</td><td>2.9 (2.1&#8211;3.6)</td><td>3.0 (2.3&#8211;3.7)</td><td>1.6 (1.1&#8211;2.2)</td><td>2.2 (1.4&#8211;3.0)</td></tr><tr><td>&#8203; Not married</td><td>211</td><td>1.8 (1.3&#8211;2.6)</td><td>3.0 (2.2&#8211;3.8)</td><td>3.2 (2.4&#8211;4.0)</td><td>1.7 (1.1&#8211;2.5)</td><td>2.3 (1.4&#8211;3.1)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>0.515</td><td>0.491</td><td>0.020</td><td>0.344</td><td>0.594</td></tr><tr><td colspan="7">Employment status</td></tr><tr><td>&#8203; Employed</td><td>644</td><td>1.8 (1.3&#8211;2.5)</td><td>3.0 (2.2&#8211;3.7)</td><td>3.2 (2.5&#8211;3.9)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.2 (1.5&#8211;3.0)</td></tr><tr><td>&#8203; Not employed</td><td>220</td><td>1.8 (1.3&#8211;2.4)</td><td>2.9 (2.0&#8211;3.5)</td><td>2.5 (1.7&#8211;3.2)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.2 (1.4&#8211;3.0)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>0.600</td><td>0.317</td><td>&lt;0.001</td><td>0.832</td><td>0.740</td></tr><tr><td colspan="7">Living with a child or person in need of care</td></tr><tr><td>&#8203; Yes</td><td>313</td><td>1.7 (1.3&#8211;2.5)</td><td>2.9 (2.0&#8211;3.7)</td><td>3.2 (2.4&#8211;3.9)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.2 (1.4&#8211;3.0)</td></tr><tr><td>&#8203; No</td><td>551</td><td>1.9 (1.4&#8211;2.4)</td><td>3.0 (2.2&#8211;3.7)</td><td>3.0 (2.2&#8211;3.6)</td><td>1.6 (1.1&#8211;2.3)</td><td>2.2 (1.5&#8211;3.0)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>0.301</td><td>0.473</td><td>0.010</td><td>0.941</td><td>0.944</td></tr><tr><td colspan="7">Self-rated health</td></tr><tr><td>&#8203; Fair or poor</td><td>407</td><td>2.1 (1.5&#8211;2.6)</td><td>3.1 (2.3&#8211;3.8)</td><td>3.0 (2.3&#8211;3.8)</td><td>1.8 (1.1&#8211;2.4)</td><td>2.3 (1.6&#8211;3.0)</td></tr><tr><td>&#8203; Good</td><td>456</td><td>1.7 (1.2&#8211;2.3)</td><td>2.8 (2.0&#8211;3.5)</td><td>3.1 (2.3&#8211;3.8)</td><td>1.5 (1.1&#8211;2.2)</td><td>2.1 (1.3&#8211;3.0)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>&lt;0.001</td><td>&lt;0.001</td><td>0.849</td><td>0.008</td><td>0.037</td></tr><tr><td colspan="7">BMI, kg/m<sup>2</sup></td></tr><tr><td>&#8203; &lt;25</td><td>689</td><td>1.8 (1.3&#8211;2.4)</td><td>2.9 (2.1&#8211;3.7)</td><td>3.0 (2.3&#8211;3.7)</td><td>1.5 (1.1&#8211;2.3)</td><td>2.2 (1.4&#8211;2.9)</td></tr><tr><td>&#8203; &#8805;25</td><td>173</td><td>2.1 (1.4&#8211;2.6)</td><td>3.1 (2.4&#8211;3.7)</td><td>3.1 (2.2&#8211;3.9)</td><td>1.9 (1.2&#8211;2.4)</td><td>2.5 (1.7&#8211;3.3)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>0.010</td><td>0.169</td><td>0.732</td><td>0.028</td><td>0.001</td></tr><tr><td colspan="7">Exercise, days/week</td></tr><tr><td>&#8203; &lt;3</td><td>684</td><td>1.9 (1.4&#8211;2.5)</td><td>3.0 (2.2&#8211;3.7)</td><td>3.1 (2.4&#8211;3.9)</td><td>1.7 (1.1&#8211;2.3)</td><td>2.3 (1.5&#8211;3.0)</td></tr><tr><td>&#8203; &#8805;3</td><td>181</td><td>1.5 (1.1&#8211;2.3)</td><td>2.7 (1.7&#8211;3.4)</td><td>2.8 (1.9&#8211;3.5)</td><td>1.3 (1.0&#8211;2.1)</td><td>2.2 (1.3&#8211;3.0)</td></tr><tr><td>&#8203; &#8203; <i>P</i> value<sup>&#8225;</sup></td><td> </td><td>&lt;0.001</td><td>&lt;0.001</td><td>0.001</td><td>0.001</td><td>0.519</td></tr></table>
04ac29034f09af0dbe8626308667e411ab501d7ed58b779e59c78d788fff5e44.png
simple
<table><tr><td></td><td>Non-smoker, non ETS exposed</td><td>Non-smoker ETS exposed</td><td>Active smoker</td></tr><tr><td>Birth weight (in Kg)</td><td>N = 8091</td><td>N = 2256</td><td>N = 6395</td></tr><tr><td>Mean Birthweight (SE)&#8224;</td><td>3.448 (0.007)</td><td>3.389 (0.014)</td><td>3.279 (0.009)</td></tr><tr><td>Crude mean difference compared to Non-Smoker, Non ETS exposed (95% CI)</td><td>-</td><td>-0.059 (-0.090 to -0.027)p &lt; 0.001</td><td>-0.168 (-0.191 to -0.146)p &lt; 0.001</td></tr><tr><td>Adjusted Mean difference* (95% CI)</td><td>-</td><td>-0.036 (-0.067 to -0.005)p = 0.025</td><td>-0.146 (-0.171 to -0.122)p &lt; 0.001</td></tr><tr><td>SGA z score</td><td>N = 8024</td><td>N = 2228</td><td>N = 6338</td></tr><tr><td>Mean Z score (SD)&#8224;</td><td>0.077 (0.014)</td><td>0.006 (0.026)</td><td>-0.237 (0.016)</td></tr><tr><td>Crude mean difference compared to Non-Smoker, Non ETS exposed (95% CI)</td><td>-</td><td>-0.070 (-0.128 to -0.013)p = 0.016</td><td>-0.314 (-0.354 to -0.273)p &lt; 0.001</td></tr><tr><td>Adjusted Mean difference* (95% CI)</td><td></td><td>-0.038 (-0.093 to 0.018)p = 0.18</td><td>-0.275 (-0.319 to -0.231)p &lt; 0.001</td></tr></table>
5d9538983d855884156657dac740104d9910b935a86b1becaa2ad8c1b8f2d119.png
complex
<table><tr><td> </td><td colspan="4">Defecation: all records</td></tr><tr><td>Variable</td><td>Pooled</td><td>Pooled</td><td>Means (n &gt; 5)</td><td>Means (n &gt; 5)</td></tr><tr><td>Data type</td><td>angular</td><td>axial</td><td>angular</td><td>axial</td></tr><tr><td>Number of observations</td><td>1,893</td><td>1,893</td><td>49</td><td>49</td></tr><tr><td>Mean vector (&#956;)</td><td>133&#176;</td><td>157&#176;/337&#176;</td><td>80&#176;</td><td>148&#176;/328&#176;</td></tr><tr><td>Length of mean vector (r)</td><td>0.013</td><td>0.052</td><td>0.043</td><td>0.209</td></tr><tr><td>Circular standard deviation</td><td>169&#176;</td><td>70&#176;</td><td>144&#176;</td><td>51&#176;</td></tr><tr><td>95% Confidence interval (-/+) for &#956;</td><td>-</td><td>-</td><td>-</td><td>121&#176;-174&#176;</td></tr><tr><td>99% Confidence interval (-/+) for &#956;</td><td>-</td><td>-</td><td>-</td><td>112&#176;-183&#176;</td></tr><tr><td>Rayleigh test (Z)</td><td>0.307</td><td>5.203</td><td>0.091</td><td>2.143</td></tr><tr><td>Rayleigh test (p)</td><td>0.736</td><td>0.006</td><td>0.914</td><td>0.117</td></tr></table>
76149ea404c3236fa38837407560cbea801581a15f53e92494d572a993a459f7.png
simple
<table><tr><td>NO.</td><td>Lesion size (cm)</td><td>GTV volume (cc)</td><td>Seed activity (mCi)/D90 (Gy)</td><td>GTV:V100/V90</td><td>Seeds numbers</td><td>Post-seed implant therapies</td><td>PS:NRS</td><td>ASIA</td><td>Ambulatory function score</td><td>RR</td><td>LR (m)</td><td>Follow-up (m)</td><td>Cause of death</td></tr><tr><td>1</td><td>1.5&#215;1.5&#215;1.0</td><td>9.9</td><td>0.5/90</td><td>92.4/95.2</td><td>7</td><td>Palliative Surgery</td><td>2-3</td><td>E</td><td></td><td>PR</td><td>13</td><td>69</td><td>MM</td></tr><tr><td>2</td><td>8.5&#215;7.5&#215;7.0</td><td>110.2</td><td>0.5/100</td><td>93.2/96</td><td>80</td><td>Seed implant</td><td>0-1</td><td>C</td><td></td><td>PR</td><td>8</td><td>11</td><td>MM</td></tr><tr><td>3</td><td>5.5&#215;4.5&#215;11</td><td>104.1</td><td>0.8/100</td><td>90.1/94.2</td><td>79</td><td>No</td><td>5-6</td><td>C</td><td></td><td>SD</td><td>39</td><td>41</td><td>MM</td></tr><tr><td>4</td><td>2.7&#215;1.5&#215;5.0</td><td>102.8</td><td>0.8/140</td><td>93.2/96.7</td><td>92</td><td>No</td><td>1-2</td><td>D</td><td></td><td>PR</td><td>32</td><td>32</td><td>MM</td></tr><tr><td>5</td><td>2.5&#215;2.0&#215;1.6</td><td>32.6</td><td>0.7/121</td><td>92.8/94.5</td><td>45</td><td>Seed implant</td><td>0-1</td><td>E</td><td></td><td>CR</td><td>34</td><td>36</td><td>MM</td></tr><tr><td>6</td><td>5.5&#215;4.1&#215;1.7</td><td>103.8</td><td>0.72/108</td><td>89.2/93.2</td><td>109</td><td>No</td><td>1-2</td><td>D</td><td></td><td>PR</td><td>19</td><td>19</td><td>MM</td></tr><tr><td>7</td><td>6.2&#215;10.7&#215;8.3</td><td>100.3</td><td>0.75/148</td><td>96.8/99.2</td><td>100</td><td>CTx</td><td>0-1</td><td>D</td><td></td><td>CR</td><td>36</td><td>36</td><td>S</td></tr><tr><td>8</td><td>8.1&#215;6.3&#215;6.8</td><td>99.6</td><td>0.73/143</td><td>97.5/99</td><td>103</td><td>No</td><td>2</td><td>E</td><td></td><td>PR</td><td>35</td><td>35</td><td>S</td></tr><tr><td>9</td><td>11.5&#215;3.1&#215;3.5</td><td>39.6</td><td>0.7/102</td><td>87.8/90.7</td><td>44</td><td>No</td><td>0-1</td><td>E</td><td></td><td>PR</td><td>21</td><td>21</td><td>S</td></tr><tr><td>10</td><td>6.0&#215;3.2&#215;4.1</td><td>73.1</td><td>0.6/150</td><td>99/99.7</td><td>122</td><td>No</td><td>1-2</td><td>E</td><td></td><td>PR</td><td>4</td><td>4</td><td>MM</td></tr><tr><td>11</td><td>1.4&#215;4.8&#215;3.9</td><td>50.5</td><td>0.64/164</td><td>95.2/95.9</td><td>98</td><td>No</td><td>2</td><td>E</td><td></td><td>PR</td><td>17</td><td>17</td><td>S</td></tr><tr><td>12</td><td>4.6&#215;3.5&#215;7.7</td><td>46.2</td><td>0.68/152</td><td>98.6/99.3</td><td>74</td><td>No</td><td>0</td><td>E</td><td></td><td>PR</td><td>3</td><td>3</td><td>S</td></tr><tr><td>13</td><td>4.5&#215;6.4&#215;4.3</td><td>27.4</td><td>0.7/152</td><td>95.1/96.4</td><td>47</td><td>No</td><td>0</td><td>E</td><td></td><td>SD</td><td>3</td><td>3</td><td>S</td></tr><tr><td>14</td><td>6.0&#215;5.0&#215;4.0</td><td>27.8</td><td>0.65/133</td><td>98.1/99.3</td><td>48</td><td>No</td><td>1</td><td>E</td><td></td><td>PR</td><td>12</td><td>12</td><td>S</td></tr><tr><td>15</td><td>6.0&#215;3.5&#215;4.5</td><td>60.5</td><td>0.74/122</td><td>93.5/96.2</td><td>85</td><td>No</td><td>3</td><td>D</td><td></td><td>PR</td><td>11</td><td>11</td><td>S</td></tr><tr><td>16</td><td>2.3&#215;1.8&#215;1.2</td><td>22.9</td><td>0.75/137</td><td>96.3/98.2</td><td>31</td><td>No</td><td>2</td><td>D</td><td></td><td>SD</td><td>2</td><td>2</td><td>S</td></tr><tr><td>17</td><td>4.8&#215;4.1&#215;5.0</td><td>28.2</td><td>0.74/183</td><td>93.2/96.3</td><td>55</td><td>Seed implant</td><td>0-1</td><td>E</td><td></td><td>SD</td><td>14</td><td>20</td><td>LR</td></tr></table>
e8623b5c99b4887711fd3482179bbb8082b0204c6105fbfc60879f2ec6d2e545.png
complex
<table><tr><td>Phase</td><td>Activity</td><td>Setting</td><td>Duration</td></tr><tr><td rowspan="10">1. Open focus group discussion</td><td>Firstly, informal conversation and <i>ice-breaking</i> activities were used to create a relaxing environment. Then a discussion was conducted to identify barriers that influence children&#8217;s recess play. Questions used were:</td><td rowspan="10">Classroom/meeting room at the school</td><td rowspan="10">30 minutes</td></tr><tr><td>&#8226; What are your experiences around recess?</td></tr><tr><td>&#8226; What do you do during recess?</td></tr><tr><td>&#8226; Who are you playing with?</td></tr><tr><td>&#8226; Who initiates play?</td></tr><tr><td>&#8226; Is there something you want to do in recess that you cannot or may not do? What was this?</td></tr><tr><td>&#8226; What do you think about your schoolyard?</td></tr><tr><td>&#8226; Can you explain what physical activity is?</td></tr><tr><td>&#8226; Do you like being physically active? Why/why not?</td></tr><tr><td>&#8226; What influences your physical activity during recess?</td></tr><tr><td>2. Go-along interview</td><td>The children pointed out where they usually played during recess, the activity they played and who they played with. A Google Earth aeria photograph of the schoolyard was used as a tool (by the moderator), to indicate where different activities took place.</td><td>Shared indoor and outdoor areas at the school</td><td>20 minutes</td></tr><tr><td>3. Post-it note activity</td><td>An open brainstorm to identify significant barriers to engaging in physical activity during recess. The groups were told to write down all the barriers that they could think of on post-it notes.</td><td>Classroom/meeting room. Gender separated groups</td><td>10 minutes</td></tr></table>
c19a3651aabe75e2a582ae2f650ac5d474a2ae7083a824750b55128286e6a653.png
simple
<table><tr><td>Response</td><td>Fraction</td><td>Acid/alkali</td><td>pH</td><td>T</td><td>t</td><td>pH&#183;T</td><td>pH&#183;pH</td><td>T&#183;t</td></tr><tr><td>Glucose</td><td>Solid</td><td>Acidic</td><td></td><td>x</td><td></td><td>x</td><td>x</td><td>-</td></tr><tr><td></td><td>Liquid</td><td>Acidic</td><td>-</td><td></td><td></td><td></td><td></td><td>-</td></tr><tr><td>Xylose</td><td>Solid</td><td>Acidic</td><td>x</td><td>x</td><td></td><td>x</td><td>x</td><td></td></tr><tr><td></td><td>Liquid</td><td>Acidic</td><td>x</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Lignin</td><td>Solid</td><td>Acidic</td><td></td><td></td><td></td><td></td><td></td><td>x</td></tr><tr><td>Glucose</td><td>Solid</td><td>Alkaline</td><td>x</td><td></td><td></td><td>x</td><td>x</td><td></td></tr><tr><td></td><td>Liquid</td><td>Alkaline</td><td>x</td><td>x</td><td></td><td></td><td></td><td>x</td></tr><tr><td>Xylose</td><td>Solid</td><td>Alkaline</td><td>x</td><td></td><td>-</td><td></td><td>x</td><td></td></tr><tr><td></td><td>Liquid</td><td>Alkaline</td><td>x</td><td></td><td>x</td><td>x</td><td>x</td><td></td></tr><tr><td>Lignin</td><td>Solid</td><td>Alkaline</td><td>x</td><td></td><td></td><td>x</td><td>x</td><td></td></tr></table>
3e6f1eb8bee1c0c08905a314eb2e7cca1de789d7274d2e5fc4499cd7ff045158.png
simple
<table><tr><td>Case no.</td><td>Sex</td><td>Age (y)</td><td>Profession</td><td>Eye</td><td>Risk Factor</td><td>Disease course</td><td>Initial diagnosis</td></tr><tr><td>P1</td><td>Female</td><td>55</td><td>Actress</td><td>Left</td><td>Eye exposure to cosmetics</td><td>4 m</td><td>AK</td></tr><tr><td>P2</td><td>Male</td><td>44</td><td>Fisherman</td><td>Left</td><td>Eye exposure to fish pond water</td><td>20d</td><td>AK</td></tr><tr><td>P3</td><td>Male</td><td>60</td><td>Farmer</td><td>Right</td><td>Mosquito entering into the eye</td><td>2 m</td><td>FK</td></tr><tr><td>P4</td><td>Female</td><td>23</td><td>Clerk</td><td>Right</td><td>Wearing contact lenses</td><td>1 m</td><td>HSK</td></tr><tr><td>P5</td><td>Male</td><td>52</td><td>Farmer</td><td>Left</td><td>Hit with an iron wire</td><td>2 m</td><td>FK</td></tr><tr><td>P6</td><td>Male</td><td>49</td><td>Farmer</td><td>Left</td><td>Eye exposed to paddy field water</td><td>45d</td><td>AK</td></tr><tr><td>P7</td><td>Female</td><td>59</td><td>Farmer</td><td>Right</td><td>Winged insect in the eye</td><td>1 m</td><td>AK</td></tr><tr><td>P8</td><td>Male</td><td>39</td><td>Upfitter</td><td>Right</td><td>Eye exposed to cement</td><td>2 m</td><td>FK</td></tr><tr><td>P9</td><td>Male</td><td>28</td><td>Fisherman</td><td>Left</td><td>Unclear</td><td>40d</td><td>HSK</td></tr><tr><td>P10</td><td>Male</td><td>37</td><td>Farmer</td><td>Right</td><td>Unclear</td><td>1 m</td><td>BK</td></tr><tr><td>P11</td><td>Male</td><td>19</td><td>Worker</td><td>Right</td><td>Eye exposed to foul water</td><td>1 m</td><td>AK</td></tr><tr><td>P12</td><td>Male</td><td>63</td><td>Farmer</td><td>Left</td><td>Injured by a stick</td><td>2 m</td><td>FK</td></tr><tr><td>P13</td><td>Male</td><td>37</td><td>Farmer</td><td>Right</td><td>Injured by a stick</td><td>1.5 m</td><td>FK</td></tr><tr><td>P14</td><td>Female</td><td>39</td><td>Farmer</td><td>Left</td><td>Injured by a stick</td><td>3 m</td><td>FK</td></tr><tr><td>P15</td><td>Female</td><td>30</td><td>Worker</td><td>Right</td><td>Injured by a pencil</td><td>2 m</td><td>FK</td></tr></table>
002b1bf2bbb7dd7ec6201174e68df6346f448cd3951e861c3f940711c769f25f.png
complex
<table><tr><td rowspan="2">Statistics</td><td colspan="2"><i>PIS_3</i></td><td colspan="2"><i>PIS_4</i></td></tr><tr><td>Fluidigm2PURC</td><td><i>reduce_amplicons</i></td><td>Fluidigm2PURC</td><td><i>reduce_amplicons</i></td></tr><tr><td colspan="5">Consensus</td></tr><tr><td>Alignment length (bp)</td><td>395</td><td>415</td><td>403</td><td>418</td></tr><tr><td>Percent gaps</td><td>27.9</td><td>30.0</td><td>1.9</td><td>4.4</td></tr><tr><td>Parsimony informative sites</td><td>19</td><td>19</td><td>11</td><td>10</td></tr><tr><td colspan="5">Unknown ploidy/occurrence</td></tr><tr><td>No. of haplotypes</td><td>18</td><td>5</td><td>14</td><td>6</td></tr><tr><td>Alignment length (bp)</td><td>395</td><td>403</td><td>403</td><td>424</td></tr><tr><td>Percent gaps</td><td>16.2</td><td>48.9</td><td>2.7</td><td>7.1</td></tr><tr><td>Parsimony informative sites</td><td>48</td><td>11</td><td>43</td><td>10</td></tr><tr><td colspan="5">Known ploidy</td></tr><tr><td>No. of haplotypes</td><td>57</td><td>&#8212;</td><td>43</td><td>&#8212;</td></tr><tr><td>Alignment length (bp)</td><td>395</td><td>&#8212;</td><td>403</td><td>&#8212;</td></tr><tr><td>Percent gaps</td><td>10.3</td><td>&#8212;</td><td>2.6</td><td>&#8212;</td></tr><tr><td>Parsimony informative sites</td><td>81</td><td>&#8212;</td><td>62</td><td>&#8212;</td></tr></table>
4f81de591628937c2eb9d11dc5e56de6f5734f5963f90e52929ae86237e186f9.png
simple
<table><tr><td></td><td><i>BVS (n = 26)</i></td><td><i>EES (n = 34)</i></td><td><i>P-value</i></td></tr><tr><td>MACE, n (%)</td><td>1 (4)</td><td>2 (6)</td><td>1.000</td></tr><tr><td>Death, n (%)</td><td>0</td><td>0</td><td></td></tr><tr><td>MI, n (%)</td><td>0</td><td>0</td><td></td></tr><tr><td>TV-Revasc., n (%)</td><td>1 (4)</td><td>2 (6)</td><td>1.000</td></tr><tr><td>Non-TV-Revasc. n (%)</td><td>0</td><td>0</td><td></td></tr></table>
6cf8141f08cf802449008df4903e8bbd7246f3c208bd9cd09f6e765fa739648e.png
complex
<table><tr><td></td><td colspan="4">Would more or better testing have produced a more effective intervention?</td></tr><tr><td>Was the intervention tested?<sup>1</sup></td><td>Yes</td><td>No</td><td>Unclear</td><td>Totals</td></tr><tr><td>Yes &#8211; extensively</td><td>4</td><td>11</td><td>1</td><td>16</td></tr><tr><td>Yes &#8211; to some degree</td><td>5</td><td>11</td><td>2</td><td>18</td></tr><tr><td>No</td><td>4</td><td>4</td><td>0</td><td>8</td></tr><tr><td>Totals</td><td>13</td><td>26</td><td>3</td><td>42</td></tr><tr><td></td><td colspan="4">Was the test phase mentioned in the published article?<sup>2</sup></td></tr><tr><td>Was the intervention tested?<sup>1</sup></td><td>Yes</td><td>No</td><td></td><td>Totals</td></tr><tr><td>Yes &#8211; extensively</td><td>10</td><td>6</td><td></td><td>16</td></tr><tr><td>Yes &#8211; to some degree</td><td>7</td><td>11</td><td></td><td>18</td></tr><tr><td>No</td><td>-</td><td>8</td><td></td><td>8</td></tr><tr><td>Totals</td><td>17</td><td>25</td><td></td><td>42</td></tr></table>
6fc6653409734852989c31caa03bfed9fe38a732bc7aa419b69062949415f424.png
simple
<table><tr><td>Knowledge items</td><td>Mean current knowledge score (1&#8211;5)</td><td>Mean desired knowledge score (1&#8211;5)</td><td>Gap<sup>a</sup></td></tr><tr><td>Dosing and creating effective treatment plans for patients using CTP</td><td>1.63</td><td>4.10</td><td>2.60</td></tr><tr><td>Health Canada's MMPR</td><td>1.88</td><td>4.20</td><td>2.43</td></tr><tr><td>Similarities and differences between dried cannabis, other forms of cannabis products, and prescription cannabinoid medications</td><td>1.83</td><td>4.14</td><td>2.41</td></tr><tr><td>Laws and regulations surrounding CTP</td><td>2.06</td><td>4.21</td><td>2.29</td></tr><tr><td>Mechanism of action of cannabis/endocannabinoid system</td><td>2.15</td><td>4.16</td><td>2.24</td></tr><tr><td>Safety, warning signs and precautions for patients using CTP</td><td>2.21</td><td>4.22</td><td>2.18</td></tr><tr><td>Alternative routes of administration of CTP</td><td>2.10</td><td>4.13</td><td>2.11</td></tr><tr><td>Potential risks of using CTP</td><td>2.39</td><td>4.20</td><td>1.96</td></tr><tr><td>Potential uses of CTP</td><td>2.57</td><td>4.13</td><td>1.79</td></tr></table>
70b765b7047f26f784076d7ae442ec0c71224cb063b8083c55e7476ff7c0a663.png
complex
<table><tr><td rowspan="2"></td><td>Tracheostomy</td><td>No tracheostomy</td><td rowspan="2">Standardized differences of mean</td></tr><tr><td>Number (%) or mean &#177; sd</td><td>Number (%) or mean &#177; sd</td></tr><tr><td>Number</td><td>267</td><td>267</td><td></td></tr><tr><td>Age</td><td>58.4 &#177; 16.6</td><td>58.9 &#177; 17.9</td><td>0.03</td></tr><tr><td>Sex (male)</td><td>171 (64.0)</td><td>171 (64.0)</td><td>0.00</td></tr><tr><td>BMI</td><td>27.9 &#177; 7.8</td><td>27.9 &#177; 15.0</td><td>0.00</td></tr><tr><td colspan="4">Geographic area</td></tr><tr><td> European countries with high income</td><td>174 (64.2)</td><td>172 (64.4)</td><td>0.02</td></tr><tr><td> Non-European countries with high income</td><td>49 (18.4)</td><td>48 (18.0)</td><td>0.01</td></tr><tr><td> Countries with middle income</td><td>44 (16.5)</td><td>47 (17.6)</td><td>0.03</td></tr><tr><td colspan="4">Type of admission</td></tr><tr><td> Medical</td><td>178 (66.7)</td><td>183 (68.5)</td><td>0.04</td></tr><tr><td> Surgical</td><td>52 (19.5)</td><td>48 (18.0)</td><td>0.04</td></tr><tr><td> Elective</td><td>19 (7.1)</td><td>21 (7.9)</td><td>0.03</td></tr><tr><td> Trauma</td><td>18 (6.7)</td><td>15 (5.6)</td><td>0.05</td></tr><tr><td colspan="4">Comorbidities</td></tr><tr><td> COPD or home ventilation</td><td>60 (22.5)</td><td>65 (24.3)</td><td>0.04</td></tr><tr><td> Diabetes mellitus</td><td>64 (23.9)</td><td>64 (23.9)</td><td>0.00</td></tr><tr><td> Chronic renal failure</td><td>27 (10.1)</td><td>23 (8.6)</td><td>0.05</td></tr><tr><td> Immunosuppression or active or hematologic neoplasm</td><td>66 (24.7)</td><td>62 (23.3)</td><td>0.04</td></tr><tr><td> Heart failure (NYHA classes III-IV)</td><td>19 (7.1)</td><td>22 (8.2)</td><td>0.04</td></tr><tr><td> Chronic liver failure (Child-Pugh Class C)</td><td>2 (0.7)</td><td>2 (0.7)</td><td>0.00</td></tr><tr><td> Cause of AHRF - pneumonia</td><td>186 (69.7)</td><td>195 (73.0)</td><td>0.07</td></tr><tr><td colspan="4">ARDS risk factor</td></tr><tr><td> No risk factor</td><td>17 (6.4)</td><td>17 (6.4)</td><td>0.00</td></tr><tr><td> Only indirect risks factor</td><td>45 (16.9)</td><td>39 (14.6)</td><td>0.06</td></tr><tr><td> Only direct risk factors</td><td>168 (62.9)</td><td>173 (65.0)</td><td>0.04</td></tr><tr><td> Both risk factors</td><td>37 (13.9)</td><td>38 (14.2)</td><td>0.01</td></tr><tr><td>ECMO use</td><td>19 (7.1)</td><td>16 (6.0)</td><td>0.05</td></tr><tr><td colspan="4">Arterial gas</td></tr><tr><td> pH</td><td>7.4 &#177; 0.1</td><td>7.4 &#177; 0.1</td><td>0.07</td></tr><tr><td> P/F ratio (mmHg)</td><td>204.1 &#177; 86.5</td><td>199.1 &#177; 63.7</td><td>0.07</td></tr><tr><td> PaCO2 (mmHg)</td><td>44.4 &#177; 13.9</td><td>44.2 &#177; 14.1</td><td>0.01</td></tr><tr><td>Non-respiratory SOFA score adjusted for missing values,</td><td>5.1 &#177; 3.4</td><td>5.1 &#177; 3.6</td><td>0.00</td></tr></table>
b3a2e9fa7bd00ad82530a002c25cc3ddefb7eb6a8aa368d65c44e8543d33b155.png
simple
<table><tr><td>Study</td><td>Diagnostic variable</td><td>Comparison</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>PPV (%)</td><td>NPV (%)</td></tr><tr><td>Casellini (34)</td><td>DPN</td><td>NIS-LL</td><td>78</td><td>92</td><td>74</td><td>93</td></tr><tr><td>Smith (9)</td><td>Distal symmetric polyneuropathy</td><td>UENS</td><td>77</td><td>67</td><td>59</td><td>83</td></tr><tr><td>Yajnik (37)</td><td>DPN</td><td>VPT</td><td>73</td><td>62</td><td>N/A</td><td>N/A</td></tr><tr><td>Eranki (41)</td><td>DPN</td><td>VPT</td><td>82</td><td>55</td><td>N/A</td><td>N/A</td></tr><tr><td>Calvet (39)</td><td>CAN &#8211; diabetes</td><td>CARTs</td><td>83</td><td>63</td><td>N/A</td><td>N/A</td></tr><tr><td>Ozaki (42)</td><td>Diabetic kidney disease</td><td>eGFR, ACR</td><td>94</td><td>78</td><td>81</td><td>93</td></tr></table>
db8afbb8ce530f3bc1bcb932572bc76aa452d504d7f74c51d15fce11338a0037.png
complex
<table><tr><td>Beat Type</td><td>Total Number</td><td>TP</td><td>TN</td><td>FP</td><td>FN</td><td>Sensitivity(%)</td><td>Specificity(%)</td></tr><tr><td>N</td><td>800</td><td>800</td><td>2943</td><td>3</td><td>0</td><td>100.00</td><td>99.90</td></tr><tr><td>PVC</td><td>289</td><td>272</td><td>3450</td><td>7</td><td>17</td><td>94.12</td><td>99.80</td></tr><tr><td>APC</td><td>1175</td><td>1166</td><td>2559</td><td>12</td><td>9</td><td>99.23</td><td>99.53</td></tr><tr><td>RBBB</td><td>900</td><td>896</td><td>2835</td><td>11</td><td>4</td><td>99.55</td><td>99.61</td></tr><tr><td>LBBB</td><td>582</td><td>574</td><td>3159</td><td>5</td><td>8</td><td>98.62</td><td>99.84</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="2">Average</td><td>98.98</td><td>99.75</td></tr></table>
9874d6001d57b4d9325841c2cce4ae1e4bf88d484e11ea639b3fee227948083c.png
simple
<table><tr><td>Anatomical region</td><td>Coordinates <i>x</i>, <i>y</i>, and <i>z</i> (mm)</td><td>Brodmann area</td><td>Cluster equiv.</td><td>Voxel <i>Z</i> score</td></tr><tr><td>Activation</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Broca's area</td><td>&#8722;34, 6, 28</td><td>44</td><td>110</td><td>5.84</td></tr><tr><td> ACC</td><td>2, 8, 40</td><td>32</td><td>228</td><td>5.72</td></tr><tr><td> SSAC</td><td>16, &#8722;26, 48</td><td>5</td><td>114</td><td>5.65</td></tr><tr><td> Wernicke's area</td><td>46, &#8722;48, 20</td><td>22</td><td>30</td><td>5.52</td></tr><tr><td> VAC</td><td>&#8722;6, &#8722;88, 38</td><td>19</td><td>31</td><td>5.32</td></tr><tr><td> CV</td><td>6, &#8722;62, &#8722;4</td><td>&#8212;</td><td>14</td><td>5.28</td></tr><tr><td> VC (V2)</td><td>24, &#8722;80, 6</td><td>18</td><td>17</td><td>5.24</td></tr><tr><td>Deactivation</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> IPL</td><td>&#8722;40, &#8722;40, 34</td><td>39/40</td><td>286</td><td>6.74</td></tr><tr><td> FP</td><td>&#8722;2, 68, &#8722;8</td><td>10</td><td>160</td><td>6.66</td></tr><tr><td> IFG PT</td><td>40, 28, 16</td><td>45</td><td>117</td><td>6.53</td></tr><tr><td> PSMA</td><td>30, 14, 44</td><td>6</td><td>348</td><td>6.34</td></tr><tr><td> PMC (M1)</td><td>&#8722;28, &#8722;18, 56</td><td>4</td><td>45</td><td>6.12</td></tr><tr><td> FEF/dl-PFC</td><td>&#8722;30, 12, 44</td><td>8/9</td><td>157</td><td>5.93</td></tr><tr><td> dl-PFC</td><td>&#8722;38, 26, 24</td><td>46</td><td>309</td><td>5.70</td></tr><tr><td> AG/FG</td><td>&#8722;40, &#8722;60, 8</td><td>39/37</td><td>177</td><td>5.58</td></tr><tr><td> ITG</td><td>&#8722;70, &#8722;22, &#8722;20</td><td>20</td><td>20</td><td>5.66</td></tr><tr><td> TP</td><td>40, 22, &#8722;44</td><td>38</td><td>12</td><td>5.64</td></tr><tr><td> CV (V1)</td><td>&#8722;14, &#8722;66, 24</td><td>17</td><td>46</td><td>5.29</td></tr></table>
3732b732614bcbcac16e7e66e4255b1405e890233d0b656add214a51c86d4300.png
simple
<table><tr><td> </td><td>Meeting days</td><td>Non-meeting days</td><td><i>P</i></td></tr><tr><td>Whole arrests</td><td> </td><td> </td><td> </td></tr><tr><td> 1-month survival, % (<i>n</i>/<i>N</i>)</td><td>3.8 (774/20 143)</td><td>3.8 (1477/38 859)</td><td> </td></tr><tr><td>Crude OR (95% CI)</td><td>1.01 (0.93&#8211;1.11)</td><td>Reference</td><td>0.802</td></tr><tr><td>Adjusted OR (95% CI)</td><td>1.01 (0.92&#8211;1.11)</td><td>Reference</td><td>0.799</td></tr><tr><td> Favorable neurologic outcome, % (<i>n</i>/<i>N</i>)</td><td>1.6 (324/20 142)</td><td>1.5 (596/38 855)</td><td> </td></tr><tr><td>Crude OR (95% CI)</td><td>1.05 (0.92&#8211;1.08)</td><td>Reference</td><td>0.488</td></tr><tr><td>Adjusted OR (95% CI)</td><td>1.02 (0.88&#8211;1.19)</td><td>Reference</td><td>0.757</td></tr><tr><td>Bystander-witnessed VF arrests with cardiac origin</td><td> </td><td> </td><td> </td></tr><tr><td> 1-month survival, % (<i>n</i>/<i>N</i>)</td><td>28.9 (275/951)</td><td>26.5 (481/1814)</td><td> </td></tr><tr><td>Crude OR (95% CI)</td><td>1.12 (0.94&#8211;1.35)</td><td>Reference</td><td>0.179</td></tr><tr><td>Adjusted OR (95% CI)</td><td>1.10 (0.92&#8211;1.33)</td><td>Reference</td><td>0.297</td></tr><tr><td> Favorable neurologic outcome, % (<i>n</i>/<i>N</i>)</td><td>19.1 (182/951)</td><td>17.9 (324/1813)</td><td> </td></tr><tr><td>Crude OR (95% CI)</td><td>1.09 (0.89&#8211;1.33)</td><td>Reference</td><td>0.413</td></tr><tr><td>Adjusted OR (95% CI)</td><td>1.04 (0.83&#8211;1.29)</td><td>Reference</td><td>0.750</td></tr></table>
eec6f1866f42f027c7cc52100a1d5a47e628b3ecc1c602bc4750cfd2d8997543.png
complex
<table><tr><td rowspan="2"></td><td rowspan="2">Point estimate</td><td rowspan="2">SE (boot)</td><td colspan="2">Bootstrapping BC 95 % CI</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td colspan="5">Visiting STI services regularly</td></tr><tr><td> Subjective norms</td><td>&#8722;0.00</td><td>0.02</td><td>&#8722;0.04</td><td>0.04</td></tr><tr><td> Perceived behavioral control</td><td>0.08</td><td>0.03</td><td>0.04</td><td>0.15<sup>a</sup></td></tr><tr><td colspan="5">Adherence to STI treatment</td></tr><tr><td> Subjective norms</td><td>0.13</td><td>0.11</td><td>0.01</td><td>0.46<sup>a</sup></td></tr><tr><td> Perceived behavioral control</td><td>0.29</td><td>0.17</td><td>0.10</td><td>0.63<sup>a</sup></td></tr><tr><td colspan="5">Taking an HIV test</td></tr><tr><td> Subjective norms</td><td>0.03</td><td>0.03</td><td>&#8722;0.01</td><td>0.09</td></tr><tr><td> Perceived behavioral control</td><td>0.03</td><td>0.02</td><td>0.01</td><td>0.07<sup>a</sup></td></tr><tr><td colspan="5">Picking up the result of HIV test</td></tr><tr><td> Subjective norms</td><td>&#8722;0.01</td><td>0.02</td><td>&#8722;0.05</td><td>0.02</td></tr><tr><td> Perceived behavioral control</td><td>0.13</td><td>0.04</td><td>0.06</td><td>0.22<sup>a</sup></td></tr></table>
565552d84bd75986e2c34d9f1fae3bba9224ce20030f1faced50cda67d7e3f74.png
simple
<table><tr><td></td><td>Children (<i>n</i> = 168), <i>M</i> (SD)</td><td>Parents (<i>n</i> = 172), <i>M</i> (SD)</td></tr><tr><td>Total anxiety</td><td>29.03 (18.47)</td><td>29.07 (14.61)</td></tr><tr><td>Separation anxiety</td><td>4.37 (3.90)</td><td>5.18 (3.62)</td></tr><tr><td>Social phobia</td><td>5.76 (3.92)</td><td>6.79 (3.74)</td></tr><tr><td>Panic disorder/agoraphobia</td><td>4.37 (4.55)</td><td>4.05 (3.42)</td></tr><tr><td>Specific phobia</td><td>4.20 (2.88)</td><td>4.63 (2.94)</td></tr><tr><td>Generalized anxiety</td><td>5.39 (3.65)</td><td>4.65 (2.61)</td></tr></table>
e9f4864b342e276a4d11318414a53abd41985d13b372cf8f839e7efb2dd6d76e.png
simple
<table><tr><td></td><td>STEMI (n = 22)</td><td>NSTEMI (n = 11)</td><td>Total (n = 33)</td></tr><tr><td>Age in years, median</td><td>62.6</td><td>62.4</td><td>62.5</td></tr><tr><td>Age &#8805; 70</td><td>9 (40.9%)</td><td>2 (18.2%)</td><td>9 (27.3%)</td></tr><tr><td>Female</td><td>5 (22.7%)</td><td>2 (18.2%)</td><td>7 (21.2%)</td></tr><tr><td>Hypertension</td><td>7 (31.8%)</td><td>8 (72.7%)</td><td>15 (45.5%)</td></tr><tr><td>Diabetes mellitus</td><td>5 (22.7%)</td><td>2 (18.2%)</td><td>7 (21.2%)</td></tr><tr><td>Dyslipidemia</td><td>19 (86.4%)</td><td>8 (72.7%)</td><td>27 (81.8%)</td></tr><tr><td>Current smoker</td><td>9 (40.9%)</td><td>6 (54.5%)</td><td>15 (45.5%)</td></tr><tr><td>Prior MI</td><td>1 (4.5%)</td><td>3 (27.3%)</td><td>4 (12.2%)</td></tr><tr><td>Prior PCI</td><td>1 (4.5%)</td><td>5 (45.5%)</td><td>6 (18.2%)</td></tr><tr><td>Prior CABG</td><td>0</td><td>0</td><td>0</td></tr><tr><td>BMI in kg/m<sup>2</sup></td><td>28.4</td><td>27.4</td><td>28.1</td></tr></table>
7a3b97afd28a32c3a842072b34c4c80d9a623a3178c333c14e0a32fd9528acb6.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">Control</td><td colspan="3">Social Media</td></tr><tr><td>T0 (n)</td><td>T1 (n)</td><td><i>p</i>-value</td><td>T0 (n)</td><td>T1 (n)</td><td><i>p</i>-value</td></tr><tr><td>MPR (mean)</td><td>0.79 &#177; 0.07 (12)</td><td>0.81 &#177; 0.05 (12)</td><td>0.56</td><td>0.75 &#177; 0.06 (12)</td><td>0.92 &#177; 0.03 (12)</td><td><i>&lt; 0.001*</i></td></tr><tr><td>MPR &lt; 1</td><td>0.64 &#177; 0.07 (7)</td><td>0.76 &#177; 0.07 (7)</td><td>0.08</td><td>0.72 &#177; 0.05 (11)</td><td>0.93 &#177; 0.05 (11)</td><td><i>&lt; 0.001*</i></td></tr><tr><td>MPR &#8805; 0.8</td><td>58% (7/12)</td><td>67% (8/12)</td><td>0.67</td><td>50% (6/12)</td><td>92% (11/12)</td><td><i>0.03</i></td></tr><tr><td>MASRI (mean)</td><td>87.8 &#177; 4.0 (12)</td><td>90.4 &#177; 2.4 (12)</td><td>0.76</td><td>85.4 &#177; 6.7 (11)</td><td>84.2 &#177; 7.7 (11)</td><td>0.44*</td></tr><tr><td>MASRI &#8805;0.8</td><td>79% (11/14)</td><td>93% (13/14)</td><td>0.28</td><td>75% (9/12)</td><td>75% (9/12)</td><td>1.0</td></tr></table>
d89eb56421e5a614c63be305b17916a92302a213b19b29a45b7a359a1fad2730.png
simple
<table><tr><td>Traits<sup>a</sup></td><td>SNPs</td><td>Chr.</td><td>Position (bp)</td><td>Allele</td><td>MAF</td><td>-Log<sub>10</sub>(P)</td><td>Allele's effect</td></tr><tr><td>RCC</td><td>TM57102</td><td>D5</td><td>8,908,622</td><td>A/G</td><td>0.36(G)</td><td>5.23</td><td>0.06</td></tr><tr><td></td><td>TM57104</td><td>D5</td><td>8,918,010</td><td>A/C</td><td>0.14(C)</td><td>5.23</td><td>0.06</td></tr><tr><td>RMDA</td><td>TM5633</td><td>A2</td><td>80,274,022</td><td>A/G</td><td>0.18(A)</td><td>5.00</td><td>&#8722;0.28</td></tr><tr><td></td><td>TM70162</td><td>D9</td><td>3,595,148</td><td>A/G</td><td>0.47(A)</td><td>6.53</td><td>&#8722;0.13</td></tr><tr><td></td><td>TM70169</td><td>D9</td><td>3,793,378</td><td>A/C</td><td>0.48(A)</td><td>6.53</td><td>&#8722;0.13</td></tr><tr><td></td><td>TM70170</td><td>D9</td><td>3,801,945</td><td>A/G</td><td>0.47(A)</td><td>6.53</td><td>&#8722;0.13</td></tr><tr><td></td><td>TM70171</td><td>D9</td><td>3,812,331</td><td>A/T</td><td>0.47(T)</td><td>6.53</td><td>&#8722;0.13</td></tr><tr><td>RGR</td><td>TM43002</td><td>A12</td><td>84,233,507</td><td>A/G</td><td>0.17(G)</td><td>5.34</td><td>0.13</td></tr></table>
257274a7caa64727d21637b822aa154a11540bd536d0af9820ac543042557998.png
complex
<table><tr><td rowspan="2"> </td><td>Unadjusted odds ratio</td><td rowspan="2"><i>p</i> value</td><td>Adjusted odds ratio</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>[95% confidence interval]</td><td>[95% confidence interval]</td></tr><tr><td>Adequate sleep</td><td> </td><td>&lt;.0001</td><td> </td><td>.9812</td></tr><tr><td> 7 hours or more</td><td>Reference </td><td> </td><td>Reference </td><td> </td></tr><tr><td> Less than 7 hours </td><td>1.34 [1.18, 1.52]</td><td> </td><td>1.00 [0.83, 1.21] </td><td> </td></tr><tr><td>Age group</td><td> </td><td> </td><td> </td><td>&lt;.0001</td></tr><tr><td> 30 to less than 45 years</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td> 45 to less than 55 years</td><td> </td><td> </td><td>2.77 [2.04, 3.76]</td><td> </td></tr><tr><td> 55 years and above</td><td> </td><td> </td><td>5.49 [3.77, 8.01] </td><td> </td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td>&lt;.0001</td></tr><tr><td> Female</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td> Male</td><td> </td><td> </td><td>2.60 [2.17, 3.12]</td><td> </td></tr><tr><td>Race/ethnicity</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Non-Hispanic white</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td> Non-Hispanic black</td><td> </td><td> </td><td>1.88 [1.20, 2.96]</td><td>.0060</td></tr><tr><td> Hispanic</td><td> </td><td> </td><td>2.94 [2.18, 3.97]</td><td>&lt;.0001</td></tr><tr><td> Other</td><td> </td><td> </td><td>1.65 [1.13, 2.41]</td><td>.0092</td></tr><tr><td>Education</td><td> </td><td> </td><td> </td><td>&lt;.0001</td></tr><tr><td> HS graduate/less</td><td> </td><td> </td><td>1.34 [1.09, 1.65]</td><td> </td></tr><tr><td> Some coll/tech/more</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td>Smoking</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Current</td><td> </td><td> </td><td>2.74 [1.98, 3.80]</td><td>&lt;.0001</td></tr><tr><td> Former</td><td> </td><td> </td><td>1.43 [1.15, 1.79]</td><td>.0016</td></tr><tr><td> Never</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td>Number of missing teeth</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 0&#8211;5</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td> 6&#8211;9</td><td> </td><td> </td><td>1.44 [1.14, 1.82]</td><td>.0024</td></tr><tr><td> 10&#8211;20</td><td> </td><td> </td><td>2.64 [2.02, 3.44]</td><td>&lt;.0001</td></tr><tr><td> More than 20</td><td> </td><td> </td><td>2.18 [1.02, 4.65]</td><td>.0445</td></tr><tr><td>Federal Poverty Level Index</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 0 to less than 1.25</td><td> </td><td> </td><td>1.82 [1.23, 2.71]</td><td>.0028</td></tr><tr><td> 1.25 to less than 2.00</td><td> </td><td> </td><td>1.62 [1.15, 2.26]</td><td>.0053</td></tr><tr><td> 2.00 to less than 4.00</td><td> </td><td> </td><td>1.60 [1.07, 2.39]</td><td>.0213</td></tr><tr><td> 4.00 and above</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td>Insurance coverage</td><td> </td><td> </td><td> </td><td>&lt;.0001</td></tr><tr><td> Yes</td><td> </td><td> </td><td>Reference</td><td> </td></tr><tr><td> No</td><td> </td><td> </td><td>1.73 [1.43, 2.10]</td><td> </td></tr><tr><td>Diabetes</td><td> </td><td> </td><td> </td><td>.1567</td></tr><tr><td> Yes</td><td> </td><td> </td><td>1.41 [0.88, 2.26]</td><td> </td></tr><tr><td> No</td><td> </td><td> </td><td>reference</td><td> </td></tr></table>
7bdb4aaddba435ed1534ecc51dc07a4c0ddb56d55e1bbf9ef44e49ce11edded6.png
simple
<table><tr><td>Primers</td><td>Sequence (5&#8242;&#8211;3&#8242;)</td></tr><tr><td>pmirGLO-HA-F</td><td>CTAGCTAGCAGCAAAAGCAGGGGAAAAC</td></tr><tr><td>pmirGLO-HA-R</td><td>CCGCTCGAGTAGTAGAAACAAGGGTGTTTTTTTC</td></tr><tr><td>pmirGLO-HA-mut-F</td><td>ATTAATGATATTCCGAAAGAAGTCC</td></tr><tr><td>pmirGLO-HA-mut-R</td><td>GGACTTCTTTCGGAATATCATTAAT</td></tr><tr><td>pmirGLO-NS-F</td><td>TACGAGCTCGCAAAAGCAGGGTGACAA</td></tr><tr><td>pmirGLO-NS-R</td><td>TGCTCTAGATAGTAGAAACAAGGGTGTTTTTTAT</td></tr><tr><td>pmirGLO-NS-mut-F</td><td>GATATCGAAACTCGGACTCTTGTTG</td></tr><tr><td>pmirGLO-NS-mut-R</td><td>CAACAAGAGTCCGAGTTTCGATATC</td></tr><tr><td>pmirGLO-PB1-F</td><td>TACGAGCTCAGCAAAAGCAGGCAAACC</td></tr><tr><td>pmirGLO-PB1-R</td><td>CCGCTCGAGTAGTAGAAACAAGGCATTTTTTCA</td></tr><tr><td>pmirGLO-PB2-F</td><td>CCGCTCGAGAGCAAAAGCAGGTCAAATATATT</td></tr><tr><td>pmirGLO-PB2-R</td><td>TGCTCTAGATAGTAGAAACAAGGTCGTTTTAAAC</td></tr><tr><td>pmirGLO-PA-F</td><td>TACGAGCTCAGCAAAAGCAGGTACTGATCC</td></tr><tr><td>pmirGLO-PA -R</td><td>CCGCTCGAGTAGTAGAAACAAGGTACTTTTTTGG</td></tr><tr><td>pmirGLO-NA-F</td><td>TACGAGCTCAGCAAAAGCAGGAGTTTAAAAT</td></tr><tr><td>pmirGLO-NA-R</td><td>CCGCTCGAGTAGTAGAAACAAGGAGTTTTTTGAAC</td></tr><tr><td>pmirGLO-NP-F</td><td>CCGCTCGAGAGCAAAAGCAGGGTAGATAATC</td></tr><tr><td>pmirGLO-NP-R</td><td>TGCTCTAGATAGTAGAAACAAGGGTATTTTTCCT</td></tr></table>